EurekaMag Full Text Articles Chapter 35,960

Carlsson, P.O.; Mattsson, G.; Liss, P.; Jansson, L.; Palm, F. 2000: Tissue oxygen tension and blood perfusion in transplanted human pancreatic islets. Diabetologia 43(Suppl 1): A29

Blangsted, A.K.; Olsen, H.B.; Sogaard, K.; Sjogaard, G. 2003: Tissue oxygenation and electromyogram in forearm extensor muscles during recovery from low force isometric contraction. Medicine and Science in Sports and Exercise 35(5 Suppl): S240

Tsai, A.G.; Intaglietta, M. 2000: Tissue oxygenation in extreme hemodilution using Dextran 70 kDa and molecular bovine hemoglobin. FASEB Journal 14(4): A5

Flaherty, J.C.; Whitt, J.B.; Chang, J.Y.; Tholfsen, D.R.; Evard, P.C.; Makower, J. 2002: Tissue penetrating catheters having integral imaging transducers and their methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1257(4)

Athanasiou, K.A.; Constantinides, G.; Lanctot, D.R. 2001: Tissue penetrating device and methods for using same. Official Gazette of the United States Patent and Trademark Office Patents 1243(1)

Baba, S. 1999: Tissue penetration and clinical efficacy of gatifloxacin, a new oral fluoroquinolone, in otorhinolaryngological infections. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 136

Mazzei, T.; Novelli, A.; Esposito, S.; Fallani, S.; Cassetta, M.I.; Conti, S. 1999: Tissue penetration and pulmonary disposition of a new cefaclor formulation in adult patients. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 54

Habler, O.P.; Messmer, K.F. 2000: Tissue perfusion and oxygenation with blood substitutes. Advanced Drug Delivery Reviews 40(3): 171-184

Winslow, R.M. 2000: Tissue perfusion with oxygen-carrying plasma expanders Myths and realities. Journal of Vascular Research 37(Suppl 1): 83

Livni, E.; Burker, M.; Hillier, S.; Rubin, R.H.; Fischman, A.J. 2001: Tissue pharmacokinetics of 11C labeled stavudine. Journal of Nuclear Medicine 42(5 Suppl): 334P

Zheng, J.H.; Au, J.L.S.; Wientjes, M.G. 1999: Tissue pharmacokinetics of doxorubicin after intraprostatic infusion. Proceedings of the American Association for Cancer Research 40: 393

Pahkla, R.; Karjagin, J.; Starkopf, J. 2003: Tissue pharmacokinetics of metronidazole. Tulunay, F C, Orme, M European collaboration: Towards drug development and rational drug therapy: 99

Zaslavsky, E.; Stewart, R.B. 2001: Tissue pick and method for use in minimally invasive surgical procedures. Official Gazette of the United States Patent and Trademark Office Patents 1246(2)

Cottler, P.S.; Price, R.J. 2003: Tissue pillars in mesenteric lymphatics evidence for intussusception during lymphangiogenesis. FASEB Journal 17(4-5): Abstract 349

Hennan, J.K.; Driscoll, E.M.; Lucchesi, B.R. 2002: Tissue plasminogen activator administration after myocardial ischemia reduces the cardioprotective effects of preconditioning. FASEB Journal 16(4): A175-A176

Malyszko, J.; Brzosko, S.; Hryszko, T.; Malyszko, J.S.; Mysliwiec, M. 2002: Tissue plasminogen activator and time on dialysis prior to transplantation are associated with structural changes in carotid arteries in renal transplant recipients. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 372A

Teesalu, T.; Kulla, A.; Asser, T.; Koskiniemi, M.; Vaheri, A. 2002: Tissue plasminogen activator as a key effector in neurobiology and neuropathology. Biochemical Society Transactions 30(2): 183-189

Tsirka, S.E. 2002: Tissue plasminogen activator as a modulator of neuronal survival and function. Biochemical Society Transactions 30(2): 222-225

Takahata, H.; Deli, M.A.; Abraham, C.S.; Kitagawa, N.; Hayashi, K.; Kaminogo, M.; Shibata, S.; Niwa, M. 2000: Tissue plasminogen activator attenuates the effect of hypoxia-reoxygenation on fluid-phase endocytosis in an in vitro model of the blood-brain barrier. Japanese Journal of Pharmacology 82(Suppl 1): 105P

Nakashima, K.; Tajima, Y.; Furukawa, S.; Mizokami, H. 2000: Tissue plasminogen activator medicinal composition. Official Gazette of the United States Patent and Trademark Office Patents 1239(5)

Moore, P.A.; Ruben, S.M.; Ebner, R. 2002: Tissue plasminogen activator-like protease. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Goeddel, D.V.; Kohr, W.J.; Pennica, D.; Vehar, G.A. 1999: Tissue plasminogen activators and derivatives thereof as produced by recombinant means. Official Gazette of the United States Patent and Trademark Office Patents 1219(2): 1532

Ecke, T.H.; Lenk, S.V.; Schlechte, H.H.; Loening, S.A. 2003: Tissue polypeptide antigen in comparison with mutations of tumour suppressor gene P53 in patients with bladder cancer. Anticancer Research 23(2A): 957-962

Ecke, T.H.; Schlechte, H.H.; Lenk, S.V.; Loening, S.A. 2002: Tissue polypeptide antigen in serum and urine, and mutation of TP53 gene in patients with bladder cancer. Journal of Urology 167(4 Suppl): 121

Yeh, L.S.; Hung, Y.C.; Kao, A.; Lin, C.C.; Lee, C.C. 2002: Tissue polypeptide specific antigen and carbohydrate antigen 125 in the early prediction of recurrent ovarian cancer. Anticancer Research 22(6B): 3669-3672

Kil, Paul J.M.; Goldschmidt, Henk M.J.; Wieggers, Bob J.A.; Koriakine, O.B.; Studer, Urs E.; De Reijke, Theo M.; Whelan, Peter; Collette, Laurence 2000: Tissue polypeptide specific antigen determinations before and during intermittent hormonal therapy in metastatic prostatic carcinoma. Journal of Urology 163(4 Suppl): 181

Malamitsi Puchner, A.; Sarandakou, A.; Vazaiou, A.; Tziotis, J.; Bartsocas, C. 2001: Tissue polypeptide-specific antigen in children and adolescents with type I diabetes mellitus. Pediatric Research 49(2): 312

Mills, C.R.; Wironen, J.F.; Hanstke, S.; Donda, R.S.; Grooms, J.M.; Bianchi, J. 2003: Tissue pooling process. Official Gazette of the United States Patent and Trademark Office Patents 1274(1)

Ramarosandratana, A.V.; Van Staden, J. 2003: Tissue position, explant orientation and naphthaleneacetic acid affect initiation of somatic embryos and callus proliferation in Norway spruce. Plant Cell Tissue and Organ Culture 74(3): 249-255

Winkler, R.A. 2004: Tissue positioning apparatus and method for protecting tissue from radiotherapy. Official Gazette of the United States Patent and Trademark Office Patents 1278(1)

Beckton Dickinson And Company 2000: Tissue preparation for surface antigen staining. BD Immunocytometry Systems Home Page (Cited May 19, ): 1-2

Bonutti, P.M. 2000: Tissue press and system. Official Gazette of the United States Patent and Trademark Office Patents 1239(3)

Gaston, S.M.; Soares, M.; Brice, M.J.; Vu, D.; Shih, J.; Chow, S.; Chang, J.T.; Upton, M.; Rosen, S.; Genega, E.; Pories, S.; Lenkinski, R. 2003: Tissue print analysis of surgically resected prostate and breast cancer specimens reveals collagen fragment fingerprints associated with tumor grade and with positive surgical margins. Proceedings of the American Association for Cancer Research 44: 37

Gaston, Sandra M.; Vu, Dang; Brice, Mark J.; Goldner, Dana L.; Rogg, Jonathan G.; Lee, Jung M.; Genega, Elizabeth M.; De Wolf, William C. 2004: Tissue print profiling of prostate needle biopsies Obtaining comprehensive tissue sampling for molecular marker analysis without compromising microscopic evaluation of the biopsy cores. Journal of Urology 171(4 Suppl): 483

Hunnell, J.E.; Cometto, S. 2004: Tissue processor. Official Gazette of the United States Patent and Trademark Office Patents 1285(4)

Cid, M.C.; Segarra, M.; Vilardell, C.; Sanchez, M.; Garcia Martinez, A.; Queralt, C.; Grau, J.M.; Hernandez Rodriguez, J. 2004: Tissue production of IL-1beta, TNFalfa and IL-6 correlates with the intensity of the systemic inflammatory response and with corticosteroid requirements in giant-cell arteritis. FASEB Journal 18(4-5): Abstract 771

Cid, M.C.; Hernandez Rodriguez, J.; Segarra, M.; Sanchez, M.; Queralt, C.; Garcia Martinez, A.; Vilardell, C.; Grau, J.M. 2003: Tissue production of transforming growth factor beta and the development of ischemic complications in giant-cell arteritis. Kidney and Blood Pressure Research 26(4): 287

Gershtein, E.S.; Polotsky, B.E.; Laktionov, K.K.; Krasil'nikov, M.A.; Davydov, M.I.; Kushlinsky, N.E. 2002: Tissue prognostic markers in non-small cell lung cancer Clinico-pathologic correlations. International Journal of Cancer Suppl (13): 150-151

Linden, J.; Glover, D.K.; Beller, G.A.; Sullivan, G.; Cassada, D.C.; Kern, J.A.; Yang, Z.; French, B.A. 2002: Tissue protection by agonists of A2A adenosine receptors. Drug Development Research 56(4): 551

Cerami, A. 2002: Tissue protective cytokines. Journal of Interferon and Cytokine Research 22(Suppl 1): S-76

Vargas, J.; Donohoe, B.M.; Anderson, S.C.; Bender, T.; Yencho, S.; Hausen, B.; Hendricksen, M.; Nielsen, J.T. 2004: Tissue punch. Official Gazette of the United States Patent and Trademark Office Patents 1278(1)

Williamson, W.P.; Berky, C.B.; Spence, P.A.; Ortiz, M. 2000: Tissue punching instrument. Official Gazette of the United States Patent and Trademark Office Patents 1235(4)

Rabah, D.M.; Begin, L.R.; Zahran, A.; Corcos, J. 2000: Tissue reaction comparison between cadaveric human fascia lata and polypropylene surgical mesh on rabbit urinary bladder. Journal of Urology 163(4 Suppl): 229

Corcos, J.; Rabah, D.M.; Speiss, P.; Begin, L.; Zahran, A. 2000: Tissue reaction comparison between cadaveric human fascia lata and two types of polypropylene mesh on rabbit urinary bladder. Neurourology and Urodynamics 19(4): 403-404

Finger, P.A.; Wys, N.L.; Wiler, J.A.; Hetke, J.; Anderson, D.J.; Altschuler, R.A. 1999: Tissue reaction with university of Michigan neuroprobe cortical placements. Society for Neuroscience Abstracts 25(1-2): 207

Samli, M.M.; Demirbas, M.; Guler, C.; Aktepe, F. 2004: Tissue reactions in the rabbit testes after transparenchymal suture fixation with six different types of suture materials. Journal of Urology 171(4 Suppl): 366

Sigler, G.; Deng, Z.D.; Peterson, D.R.; Glancy, T.P.; Stupp, S.I. 2001: Tissue reactive adhesive compositions. Official Gazette of the United States Patent and Trademark Office Patents 1253(1)

Laufer, M.D.; Cerier, J.C.; Cruz, A.G. 2002: Tissue reconfiguration. Official Gazette of the United States Patent and Trademark Office Patents 1265(3)

Sicard, R.E.; Mand, W.A. 2000: Tissue regeneration evokes a milder inflammatory response than wound repair. Wound Repair and Regeneration 8(4): 343

Cima, L.G.; Cima, M.J. 2003: Tissue regeneration matrices by solid free-form fabrication techniques. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Spievack, A.R. 2003: Tissue regenerative composition, method of making, and method of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1271(2)

Spievack, A.R. 2003: Tissue regenerative compositions for cardiac applications, method of making, and method of use thereof. Official Gazette of the United States Patent and Trademark Office Patents 1271(3)

Teumer, J.; Ronfard, V.; Xu, L.; Crews, J.; Kriwet, K.; Parenteau, N.; Hardin Young, J. 2000: Tissue remodeling and cellular persistence in skin construct implants. Wound Repair and Regeneration 8(5): A434

Popoli, A.L.; Sharp, D.C.; Buhi, W.C.; Smith, M.F.; Kojima, F.N.; Porter, M.B.; Pelehach, L.M.; Dixon, L. 2000: Tissue remodeling and de novo protein synthesis in follicles of pony mares A model for ovulation. Biology of Reproduction 62(Suppl 1): 174-175

Knowlton, E.W. 2002: Tissue remodeling apparatus containing cooling fluid. Official Gazette of the United States Patent and Trademark Office Patents 1255(4)

Gordon, E.I.; Turdiu, P. 1999: Tissue removal. Official Gazette of the United States Patent and Trademark Office Patents 1226(1)

Dubrul, W.; Fulton, R.E.stis IIi 2004: Tissue removal device and method. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)

Dubrul, W.R.; Fulton, R.E.; Curtis, R.M. 2003: Tissue removal methods and apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Chang, Henry Ping 2004: Tissue removal pen. Official Gazette of the United States Patent and Trademark Office Patents 1282(1)

Weber, Paul J.; Da Silva, Luiz B.; Rubenchik, Alexander M. 2004: Tissue removal using biocompatible materials. Official Gazette of the United States Patent and Trademark Office Patents 1284(3)

Perez, B.E.; Moran, M.E.; Parekh, A.R.; Desai, P.J.; Calvano, C.J.; Newkirk, R.E. 1999: Tissue removal utilizing the Steiner Morcellator within a LapSac Effect of a fluid filled environment. Journal of Endourology 13(Suppl 1): A4

Rizoiu, I.M.; Kimmel, A.I. 2001: Tissue remover and method. Official Gazette of the United States Patent and Trademark Office Patents 1248(1)

Houser, R.U. 1999: Tissue removing catheter and rf cutting method. Official Gazette of the United States Patent and Trademark Office Patents 1220(1): 311

Re, R.N. 2004: Tissue renin angiotensin systems. Medical Clinics of North America 88(1): 19-38

Sawant, S.P.; Dnyanmote, A.V.; Latendresse, J.R.; Mehendale, H.M. 2003: Tissue repair A key player in increased carbon tetrachloride-hepatotoxicity in type 2 diabetic rats. Hepatology 38(4 Suppl 1): 575A

Mehendale, H.M. 2002: Tissue repair Final determinant of hepatotoxic outcome. International Journal of Toxicology 21(6): 531-532

Pesce, C.; Clapasson, A.; Valente, S.; Passarello, S. 2003: Tissue repair and remodelling in extravasation mucocele. Histopathology 42(5): 516-517

Vaidya, V.S.; Shankar, K.; Chen, M.; Lock, E.A.; Bucci, T.J.; Mehendale, H.M. 2002: Tissue repair as a mechanism of protection from acute renal failure. FASEB Journal 16(5): A957

Lin, S.T.; Krebs, S.L. 1999: Tissue repair device. Official Gazette of the United States Patent and Trademark Office Patents 1228(5)

Yamamoto, R.K.; Kwan, M.K.; Pacetti, S.D. 2004: Tissue repair matrix. Official Gazette of the United States Patent and Trademark Office Patents 1284(3)

Bonutti, P.M. 2003: Tissue repair method. Official Gazette of the United States Patent and Trademark Office Patents 1276(4)

Plaas, A.H.; West, L.; Wlong Palms, S.; Nelson, F. 2000: Tissue repair processes can be monitored by the expression of specific glycosaminoglycan microstructures. Cell Biology International 24(12): 998

Weis Fogh, Ulla Sivertsen 2001: Tissue repair promoting composition. Official Gazette of the United States Patent and Trademark Office Patents 1250(1)

Colleran, D.; Gabriel, S. 2003: Tissue repair system. Official Gazette of the United States Patent and Trademark Office Patents 1277(1)

Gu, D.; Chandler, L.A.; Printz, M.; Nguyen, T.; Gonzalez, A.M.; D'andrea, M.; Phillips, L.; Pierce, G.F.; Sosnowski, B. 2000: Tissue repair using matrix-dependent gene delivery. Tissue Engineering 6(6): 702

Tunn, R.; Bettin, S.; Fischer, W. 1999: Tissue replacement by tension-free insertion of prolene tape in urinary incontinence Technical details, indications, specifications, results. Neurourology and Urodynamics 18(4): 298-299

Macrae, F.C. 1999: Tissue requirements Amino acids for gut function. Amino Acids 17(1): 91

Hornick, J.L.; Van Eenaeme, C.; Istasse, L. 1999: Tissue requirements Amino acids for muscle growth. Amino Acids 17(1): 91

Alferness, C.A.; Gonzalez, H.X. 2002: Tissue resection device, system and method. Official Gazette of the United States Patent and Trademark Office Patents 1264(4)

Goble, C.C.O.; Penny, K.; Hancock, C.P.; Amoah, F. 2004: Tissue resurfacing. Official Gazette of the United States Patent and Trademark Office Patents 1281(3)

Weber, Paul J.; Da Silva, Luiz B.; Rubenchik, Alexander M. 2004: Tissue resurfacing using biocompatible materials. Official Gazette of the United States Patent and Trademark Office Patents 1281(4)

Bester, L.W.; Walsh, D.A. 2001: Tissue retractor adapted for the attachment of an auxiliary element. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)

Sava, G.A. 1999: Tissue retractor and method for use. Official Gazette of the United States Patent and Trademark Office Patents 1225(1)

Foley, K.T.; Smith, M.M.; Clayton, J.B.; Moctezuma, J. 1999: Tissue retractor for use through a cannula. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)

Austin, G.; Austin, J.T.; Picha, G.J. 2000: Tissue retractor retention band. Official Gazette of the United States Patent and Trademark Office Patents 1236(3)

Bjornsson, C.S.; Huebner, E. 2002: Tissue rotation chamber for electrophysiology, microinjection, and microdissection. Biotechniques 33(1): 38 40 42

Overaker, D.W.; Contiliano, J.H. 2004: Tissue scaffold anchor for cartilage repair. Official Gazette of the United States Patent and Trademark Office Patents 1283(1)

Soe, G.; Aoshima, M.; Takada, K. 2001: Tissue sealant containing fibrinogen, thrombin and carboxymethyl cellulose or salt thereof. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)

Mulier, P.M.J.; Hoey, M.F. 2002: Tissue sealing electrosurgery device and methods of sealing tissue. Official Gazette of the United States Patent and Trademark Office Patents 1261(4)

Magnacca, K.N.; Brown, M.J.F. 2010: Tissue segregation of mitochondrial haplotypes in heteroplasmic Hawaiian bees: implications for DNA barcoding. Molecular Ecology Resources 10(1): 60-68

Miller, C.P.; Collini, M.D.; Tran, B.D.; Santilli, A.A. 2000: Tissue selective compounds in the treatment of endometrial proliferation. Official Gazette of the United States Patent and Trademark Office Patents 1239(1)

Miller, C.P.; Collini, M.D.; Tran, B.D.; Santilli, A.A. 2001: Tissue selective compounds in the treatment of ovarian cancer. Official Gazette of the United States Patent and Trademark Office Patents 1246(3)

Miller, C.P.; Collini, M.D.; Tran, B.D.; Santilli, A.A. 2001: Tissue selective compounds in the treatment of prostate cancer or benign prostate hypertrophy. Official Gazette of the United States Patent and Trademark Office Patents 1246(1)

Lotinun, S.; Westerlind, K.C.; Sibonga, J.D.; Turner, R.T. 2000: Tissue selective effects of continuous release of catecholestrogens on bone, uterus and mammary gland in ovariectomized growing rats. Journal of Bone and Mineral Research 15(Suppl 1): S452

Tsuji, A.; Yamato, T.; Ojima, K.; Ichikawa, K.; Kusama, H.; Kojima, M. 2002: Tissue selectivity of an insulin secretagogue, KAD-1229. Japanese Journal of Pharmacology 88(Suppl 1): 160P

Yamada, S.; Ohkura, T.; Kimura, R. 1999: Tissue selectivity of in vivo alpha1-adrenoceptor binding of KMD-3213 in rats. European Urology 36(Suppl 1): 113

Eckert, T.; Neugebauer, B.; Schwanstecher, C.; Schwanstecher, M. 2003: Tissue selectivity of the antidiabetic agent nateglinide Study on recombinant human KATP-channels. Naunyn-Schmiedeberg's Archives of Pharmacology 367(Suppl 1): R67

Chin, A.K. 1999: Tissue separation cannula. Official Gazette of the United States Patent and Trademark Office Patents 1227(3)

Chin, A.K. 2001: Tissue separation cannula and method. Official Gazette of the United States Patent and Trademark Office Patents 1244(3)

Chin, A.K. 1999: Tissue separation cannula with dissection probe and method. Official Gazette of the United States Patent and Trademark Office Patents 1219(4): 3208

Dubrul, W.R.; Fulton, R.E. 2003: Tissue separation medical device and method. Official Gazette of the United States Patent and Trademark Office Patents 1273(1)

Chin, A.K. 2000: Tissue separation method. Official Gazette of the United States Patent and Trademark Office Patents 1232(2)

Lin, T.; Sandusky, S.B.; Xue, H.; Fishbein, K.; Spencer, R.; Rao, M.; Francomano, C.A. 2003: Tissue specific FGFR3 transgenic mouse models for thanatophoric dysplasia type II. American Journal of Human Genetics 73(5): 323

Diel, P.; Engelhaupt, A.; Vollmer, G.; Laudenbach Leschowsky, U.; Schmidt, S.; Michna, H.; Fritzemeier, K.H. 2001: Tissue specific action of the phytoestrogen genistein on COX II and clusterin mRNA expression in the uterus and vcava of ovariectomized rats. Experimental and Clinical Endocrinology and Diabetes 109(Suppl 1): S55

Kontoyiannis, D.; Pasparakis, M.; Clausen, B.E.; Forster, I.; Pizarro, T.T.; Cominelli, F.; Kollias, G. 2000: Tissue specific activation of targeted TNFDELTAARE and TNF-RI alleles reveal a differential role for myeloid cells in the development of TNF mediated Crohns-like disease and arthritis. Scandinavian Journal of Immunology 51(Suppl 1): 85

Henderson, D.R.; Schuur, E.R. 2004: Tissue specific adenoviral vectors. Official Gazette of the United States Patent and Trademark Office Patents 1278(2)

Weitzman, S.; Thimmapaya, B.; Anderson, L. 2000: Tissue specific adenovirus vectors for breast cancer treatment. Official Gazette of the United States Patent and Trademark Office Patents 1237(1)

Smyth, L.J.C.; Kirby, J.A.; Eghtesad, M.; Harrison, J.; Cunningham, A.C. 1999: Tissue specific adhesion events of intra-epithelia lymphocytes and alveolar epithelium in the lung. Immunology 98(Suppl 1): 137

Watanabe, F.; Furuya, E. 1999: Tissue specific alternative splicing of brain type isozyme of fructose 6-phosphate 2-kinase/fructose2,6-bisphosphatase. FASEB Journal 13(7): A1409

Cox, Robert Harold 2001: Tissue specific alternative splicing of the large conductance, Ca2+ activated K+ channel. Biophysical Journal 80(1 Part 2): 220a-221a

Cao, Y.; Schubert, K.R. 2000: Tissue specific and developmentally regulated expression of the soybean nodule IMP dehydrogenase gene and in situ localization of IMPDH mRNA. Plant Biology (Rockville) : 182

Rashotte, A.M.; Muday, G.K. 1999: Tissue specific and gravity responsive auxin transport is mediated by multiple genes. Plant Biology (Rockville) : 156

Henderson, D.R.; Schuur, E.R. 1999: Tissue specific and tumor growth supperssion by adenovirus comprising prostate specific antigen. Official Gazette of the United States Patent and Trademark Office Patents 1219(3): 2418

Fukiage, C.; Nakajima, T.; Higashine, M.; Azuma, M.; Shearer, T.R. 1999: Tissue specific calpain RT88 from rat retina Splice variant of P94. IOVS Investigative Ophthalmology and Visual Science 40(4): S606

Fukiage, C.; Nakajima, T.; Azuma, M.; Shearer, T.R. 2000: Tissue specific calpains from rat retina. IOVS Investigative Ophthalmology and Visual Science 41(4): S879

Helguera, G.; Song, M.; Olcese, R.; Toro, L.; Stefani, E. 2000: Tissue specific changes in expression levels of Ca2+ and K+ channels during pregnancy. Biophysical Journal 78(1 Part 2): 350A

Tesarova, M.; Mayr, J.A.; Wenchich, L.; Hansikova, H.; Eleder, M.; Blahova, K.; Sperl, W.; Zeman, J. 2002: Tissue specific depletion of mitochondrial DNA in two boys with Alpers syndrome. European Journal of Human Genetics 10(Suppl 1): 207

Sacaze, C.; Henry, S.; Icart, J.; Mariame, B. 2001: Tissue specific distribution of Epstein-Barr virus BZLF1 gene variants in nasopharyngeal carcinoma bearing patients. Virus Research 81(1-2): 133-142, 4 December

Benton, C.; Bonen, A. 2002: Tissue specific effects of PPAR activation on the expression of fatty acid transporters. FASEB Journal 16(4): A31-A32

Burger, A.G. 2000: Tissue specific effects of Triac Evidence in rats and humans. Endocrine Journal 47(Suppl August): 100

Josyula, S.; Lu, L.J.W.; Salazar, J.J.; Snyderwine, E.G.; Anderson, L.M. 1999: Tissue specific effects of enzyme inducers on DNA damage caused by the food mutagen 2-amino-3-methylimidazo quinoline in patas monkey fetuses. Proceedings of the American Association for Cancer Research 40: 150

Jones, P.S.; White, I.N. 1999: Tissue specific effects of selective estrogen receptor modulators. Proceedings of the American Association for Cancer Research 40: 158

Stolze, I.; Berchner Pfannschmidt, U.; Freitag, P.; Frede, S.; Wotzlaw, C.; Acker, H.; Fandrey, J. 2002: Tissue specific erythropoietin gene regulation Comparison between human neuroblastoma and hepatoma cell lines. Pfluegers Archiv European Journal of Physiology 443(Suppl 1): S168

Williams, G.R. 1999: Tissue specific expression and T3 regulated splicing of two novel thyroid hormone receptor beta variants. Journal of Endocrinology 160(Suppl ): OC22

Martin, L.A.; Reynolds, E.R. 2000: Tissue specific expression and genetic interaction of bang-sensitive paralytic mutants. Journal of the Pennsylvania Academy of Science 73(Suppl ): 168-169

Wooley, A.H.; Thoene, J. 2001: Tissue specific expression and regulation of CTNS. American Journal of Human Genetics 69(4 Suppl): 483

Stiner, L.M.; Wheatly, M.G.; Zhang, Z.; Rogers, J.V.; Hull, B.E. 2001: Tissue specific expression of NCX throughout the crayfish molting cycle. FASEB Journal 15(4): A412

Dannull, J.; Patel, B.; Pang, S.; Kaboo, R.; Belldegrun, A. 1999: Tissue specific expression of a prostate-specific antigen promoter/enhancer in an adenoviral vector used in a human prostate cancer SCID mouse model. Journal of Urology 161(4 Suppl): 127

Maloney, C.A.; Gosby, A.K.; Phuyal, J.L.; Bryson, J.M.; Caterson, I.D. 2001: Tissue specific expression of acetyl-CoA carboxylase, fatty acid synthase and carnitine palmitoyl transferase I in weanling rats exposed to a low protein diet in utero. Diabetologia 44(Suppl 1): A 29

Li, W.; Denzin, L.; Hou, W.; Weber, E.; Bromme, D. 2001: Tissue specific expression of cathepsins and antigen presentation. Inflammation Research 50(Suppl 3): S159

Luedeking, A.; Koehler, A. 2002: Tissue specific expression of putative MXR related genes in the mussel Mytilus edulis. Marine Environmental Research 54(3-5): 461

Kanda, S.; Nagao, T.; Adachi Akahane, S. 2000: Tissue specific expression of splice variants of the L-type Ca2+ channel alpha1C subunit in rats. Japanese Journal of Pharmacology 82(Suppl 1): 82P

Muller, E.A.; Danner, D.J. 2002: Tissue specific expression of the branched-chain alpha-ketoacid dehydrogenase kinase. American Journal of Human Genetics 71(4 Suppl): 334

Otsuka, N.; Ikeda, H.; Tanaka, S.; Ishizu, A.; Yoshiki, T. 2003: Tissue specific expression of the env protein in fetus rats carrying a full length HERV-R gene. AIDS Research and Human Retroviruses 19(Suppl): S-67

Anonymous 2000: Tissue specific expression of the gene Gus after testosterone treatment in relevance to lysosomal beta-glucuronidase activity and androgen-dependent pheromones in laboratory mice. Doklady Akademii Nauk 374(3): 408-410

Zheng, Q.; Zhou, G.; Chen, Y.; Parker, A.; Lee, B. 2002: Tissue specific expression of type X collagen in hypertrophic chondrocytes is specified by cis elements in both the Col10a1 promoter and second intron. American Journal of Human Genetics 71(4 Suppl): 315

Di, Y., P.P.; Wu, Reen 2000: Tissue specific gene regulation of a novel secretory protein in upper respiratory tracts, spurt. Molecular Biology of the Cell 11(Suppl): 434a-435a

Webster, K.A.; Bishopric, N.H.; Murphy, B.; Laderoute, K.R.; Green, C.J. 2001: Tissue specific hypoxia regulated constructs. Official Gazette of the United States Patent and Trademark Office Patents 1245(3)

Raben, N.; Lu, N.; Rivera, Y.; Nagaraju, K.; Hopwood, J.; Umapathysivam, K.; Meikle, P.; Plotz, P. 2001: Tissue specific inducible expression of the human acid alpha-glucosidase gene in GAA knockout mice; implications for therapy. European Journal of Human Genetics 9(Suppl 1): C076

Tomioka, K.; Sakamoto, M.; Matsumoto, A.; Tanimura, T. 1999: Tissue specific induction of circadian rhythm by temperature cycle in Drosophila melanogaster. Zoological Science 16(Suppl ): 94

Faist, V.; Wenzel, E.; Tasto, S.; Mueller, C.; Erbersdobler, H.F. 1999: Tissue specific induction of phase I and II xenobiotic enzymes and oxygen free radical metabolism in rats fed alkali-treated protein containing high levels of lysinoalanine. FASEB Journal 13(4 Part 1): A220

Bruyere, H.; Barrett, I.J.; Kalousek, D.K.; Robinson, W.P. 1999: Tissue specific involvement in fetal trisomy 16. American Journal of Human Genetics 65(4): A173

Bagnall, A.; Webb, D.; Kotelevtsev, Y. 2002: Tissue specific knockout of the mouse endothelin B receptor. Clinical Science (London) 103(1): 15P

Nakamura, S.; Tanaka, K.; Matsumoto, T. 2003: Tissue specific mitochondrial DNA deletions in aged and irradiated mice. Journal of Radiation Research 44(4): 403

Sugama, S.; Conti, B.; Kim, Y.; Kim, H.; Tinti, C.; Baker, H.; Joh, T.H. 1999: Tissue specific modulation of IL-18 in response to ACTH. Society for Neuroscience Abstracts 25(1-2): 942

Sazonova, O.V.; Blishchenko, E.Y.; Leontiev, K.V.; Khaidukov, S.V.; Amchislavsky, E.I.; Starikova, E.A.; Sokolov, D.I.; Freidlin, I.S.; Yatskin, O.N.; Philippova, M.M.; Karelin, A.A.; Ivanov, V.T. 2003: Tissue specific peptide pools Fine tuning of cell proliferation rate in tissues. Biopolymers 71(3): 301-302

Isaacs, J.T.; Denmeade, S.R.; Christensen, S.B.; Lilja, H. 2002: Tissue specific prodrug. Official Gazette of the United States Patent and Trademark Office Patents 1259(4)

Eckert, R.L.; Crish, J.F. 2001: Tissue specific promoters and transgenic mouse for the screening of pharmaceuticals. Official Gazette of the United States Patent and Trademark Office Patents 1252(1)

Mackenzie, P.I.; Gregory, P.A.; Ishii, Y.; Hansen, A.J. 2000: Tissue specific regulation of UDP glucuronosyltransferases. Drug Metabolism Reviews 32(Suppl 1): 7

Huang, Y.; Wang, D. 2002: Tissue specific regulation of vanilloid receptor 1 by salt loading and capsaicin treatment. FASEB Journal 16(5): A831

Korac, B.; Buzadzic, B.; Buzadzic, B. 2000: Tissue specific response of glutathione peroxidase activity to nitric oxide in cold exposed rats. Nitric Oxide 4(3): 222-223

Hori, H.; Sasaoka, T.; Wada, T.; Ishiki, M.; Ishihara, H.; Kobayashi, M. 2001: Tissue specific roles of lipid phosphatase SHIP2 and its involvement in the insulin resistant states. Diabetes 50(Suppl 2): A400

Alexander, C.; Bhattacharya, S.S.; Wissinger, B. 2002: Tissue specific splice variants of the human A-C1 Ha-Ras suppressor gene. American Journal of Human Genetics 71(4 Suppl): 328

Vestrheim, O.; Syed, M.; Lundin, M. 2002: Tissue specific transcription of major histocompatibility complex class II in Atlantic salmon. Aquaculture 204(3-4): 247, 11 February

Simonet, William Scott 2001: Tissue specific transgene expression. Official Gazette of the United States Patent and Trademark Office Patents 1248(5)

Bovolenta, P.; Lopez Rios, J.; Martinez Morales, J.R.; Signore, M.; Were, F.; Simeone, A. 2001: Tissue specification of the vertebrate optic vesicle Contribution of Otx and Six genes. Development Growth and Differentiation 43(Suppl): S86

Clarke, L.; Jordan, P.; Boavida, M.G. 1999: Tissue specificity in alternative splicing of the human mismatch repair gene hMSH2. European Journal of Human Genetics 7(Suppl 1): 98

Koga, Y.; Akita, Y.; Iwanaga, R.; Kato, H. 1999: Tissue specificity in the mitochondrial tRNA processing implicates the clinical heterogeneity in mitochondrial disorders. American Journal of Human Genetics 65(4): A278

Mitrofanova, E.; Roberson, E.; Daniels, W.; Seregina, T.; Link, C. 2002: Tissue specificity of expression of rat sodium iodide symporter gene in human normal and cancer cells. Proceedings of the American Association for Cancer Research 43: 83

Suryawan, A.; O'connor, P.M.; Orellana, R.A.; Nguyen, H.V.; Bush, J.A.; Liu, C.W.; Davis, T.A. 2004: Tissue specificity of the protein synthetic response to insulin and amino acids in neonatal pigs. FASEB Journal 18(4-5): Abstract 371

Bush, J.A.; Nguyen, H.V.; Beckett, P.R.; Fiorotto, M.L.; Burrin, D.G.; Vann, R.C.; Suryawan, A.; Reeds, P.J.; Davis, T.A. 2000: Tissue specificity of the protein synthetic response to insulin-like growth factor-1 in the neonate. FASEB Journal 14(4): A767

Nagle, M.G. 2001: Tissue specimen carrier. Official Gazette of the United States Patent and Trademark Office Patents 1246(1)

Burbank, F.H.; Quick, R.L.; Louw, J.F.; Jones, M.L.; Lubock, P. 2002: Tissue specimen encapsulation device and method thereof. Official Gazette of the United States Patent and Trademark Office Patents 1255(1)

Burbank, F.H.; Lubock, P. 2003: Tissue specimen isolating and damaging device and method. Official Gazette of the United States Patent and Trademark Office Patents 1277(2)

Vassiliades, T.A.J.; Deacon, J. 2004: Tissue spreader with force measurement, force indication or force limitation. Official Gazette of the United States Patent and Trademark Office Patents 1282(1)

Jho, H.D.; Redmond, J.A. 2000: Tissue spreading instrument for use in narrow passage. Official Gazette of the United States Patent and Trademark Office Patents 1230(2)

Fox, W.D.; Knight, G.W.; Hamann, D.L.; Berky, C.B. 1999: Tissue stabilization device for use during surgery. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)

Hunt, J.V.; Berky, C.B.; Fox, W.D.; Knight, G.W.; Hamann, D.L. 1999: Tissue stabilization device for use during surgery having a segmented shaft. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)

Fox, W.D.; Hamann, D.L.; Berky, C.B.; Knight, G.W. 1999: Tissue stabilization device for use during surgery having remotely actuated feet. Official Gazette of the United States Patent and Trademark Office Patents 1219(1): 310-311

Berky, C.B.; Fox, W.D.; Knight, G.W.; Hamann, D.L. 2001: Tissue stabilization device for use during surgery having spherical curved feet. Official Gazette of the United States Patent and Trademark Office Patents 1243(4)

Green, H.L.onard II.W.llin, J.K. 2003: Tissue stabilizer and methods of use. Official Gazette of the United States Patent and Trademark Office Patents 1266(4)

Williamson, W.P.Iv; Spence, P.A.; Ortiz, M.V.; Keller, G.A.; Green, H.L.onard, II 2002: Tissue stabilizer having an articulating lift element. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)

Wheeler, A.D. 1999: Tissue staple remover. Official Gazette of the United States Patent and Trademark Office Patents 1223(5)

Young, C.L. 2000: Tissue stimulation apparatus for wheelchairs and the like. Official Gazette of the United States Patent and Trademark Office Patents 1230(3)

Burmeister, P.H.; Euteneuer, C.L.; Brown, B.J.; Fordenbacher, P.J.; Vrba, A.C. 2002: Tissue supporting devices. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Cid, M.C.; Vilardell, C. 2001: Tissue targeting and disease patterns in systemic vasculitis. Best Practice and Research. Clinical Rheumatology 15(2): 259-279

Garrison, A.G.; Gillette, W.; Hooson, K.; Knauer, S.; Moon Mcdermott, L.; Zack, P.; Gill, S.; Wolf, J.; Colagiovanni, D.B. 2000: Tissue targeting and efficacy of MiKasome versus conventional amikacin +- cefepime in a rat S aureus pneumonia model. Abstracts of the General Meeting of the American Society for Microbiology 100: 26

Lee, J.J. 2002: Tissue tensioning electrotheraphy device. Official Gazette of the United States Patent and Trademark Office Patents 1258(2)

Lee, J.J. 2004: Tissue tensioning electrotherapy device. Official Gazette of the United States Patent and Trademark Office Patents 1287(1)

Cemek,M.; Buyukokuroglu,M.E.; Yurumez,Y.; Yavuz,Y.; Aslan,A.; Buyukben,A.; Aymelek,F. 2010: Tissue trace and major element levels in organophosphate insecticide fenthion toxicity in rats prophylactic and therapeutic effect of exogenous melatonin. Ecotoxicology And Environmental Safety: 2, 206-212

Tada, H.; Toide, H.; Naito, S.; Kurosaki, K.; Ueda, M.; Ito, S.; Shinbo, G.; Hoshizaki, H.; Oshima, S.; Taniguchi, K.; Nogami, A. 2003: Tissue tracking allows rapid and accurate visual evaluation of the origin of ventricular tachycardia. Circulation 108(17): IV427

Johnson, W.Dudley 2001: Tissue traction device. Official Gazette of the United States Patent and Trademark Office Patents 1249(4)

Lesort, M.; Zhang, J.; Tucholski, J.; Chun, W.; Johnson, G.V.W. 2000: Tissue transglutaminase A possible role in Alzheimers disease and Huntingtons disease. Journal of Neurochemistry 74(Suppl ): S96

Lesort, M.; Tucholski, J.; Miller, M.L.; Johnson, G.V. 2000: Tissue transglutaminase: a possible role in neurodegenerative diseases. Progress in Neurobiology 61(5): 439-463

Riseborough, K.; Swift, G.L.; King, L.; Crimmins, R. 2000: Tissue transglutaminase A useful test for coeliac disease?. Gut 46(11): A48

Piacentini, M.; Colizzi, V. 1999: Tissue transglutaminase: apoptosis versus autoimmunity. Immunology Today 20(3): 130-134

Kocna, P.; Vanickova, Z.; Perusicova, J.; Dvorak, M. 2001: Tissue transglutaminase Serology markers of coeliac disease. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S101

L.I.cono, O.; Nardacci, R.; Ciccosanti, F.; Falasca, L.; Craxi, A.; Antonucci, G.; Ippolito, G.; Piacentini, M. 2002: Tissue transglutaminase and hepatic fibrogenesis in HCV infected patients and in experimental mouse model. Hepatology 36(4 Part 2): 256A

Chatzicostas, C.; Roussomoustakaki, M.; Drygiannakis, D.; Niniraki, M.; Koulentaki, M.; Tzardi, M.; Kouroumalis, E.A. 2001: Tissue transglutaminase antibodies and celiac disease in patients with primary biliary cirrhosis and autoimmune cholangitis. Gastroenterology 120(5 Suppl 1): A 391

Jarzabek Chorzelski, M.; Suljej, J.; Rajadhyaksha, M.; Jablonska, S.; Kumar, V. 2000: Tissue transglutaminase antibodies as compared to endomysial antibodies in dermatitis herpetiformis. FASEB Journal 14(6): A1235

Biagi, F.; Adragna, A.D.; Ansaldi, N.; Perrucci, V.; Magazzu, G.; Di Pasquale, G.; Corvaglia, L.; Spina, M.; Calabro, A.; Renzi, D.; Vicentini, L.; Dapporto, M.; Corazza, G.R. 2000: Tissue transglutaminase antibodies in celiac disease An Italian multicentric study. JPGN 31(Suppl 3): S9

Weidenhiller, M.; Winterkamp, S.; Schwab, D.; Hahn, E.G.; Schuppan, D.; Raithel, M. 2001: Tissue transglutaminase antibodies in patients with confirmed food allergy. Gastroenterology 120(5 Suppl 1): A 216

Murray, J.A.; Herlein, J.; Goeken, J.A. 1999: Tissue transglutaminase antibodies lack sensitivity for celiac disease. Gastroenterology 116(4 Part 2): A910

Chan, A.W.; Fritzler, M.J.; Butzner, J.D. 2000: Tissue transglutaminase antibody as a screening test for celiac disease. JPGN 31(Suppl 2): S8

Caproni, M.; Cardinali, C.; Renzi, D.; Calabrò, A.; Fabbri, P. 2001: Tissue transglutaminase antibody assessment in dermatitis herpetiformis. British Journal of Dermatology 144(1): 196-197

Weile, B.; Heegaard, N.H.H.; Hoier Madsen, M.; Wiik, A.; Krasilnikoff, P.A. 2000: Tissue transglutaminase autoantibodies in children and young adults with gastrointestinal and/or growth problems. JPGN 31(Suppl 2): S216

Conrad, K.; Roggenbuck, D.; Porstmann, T.; Moeller, A.; Schulz, M.; Henker, J. 1999: Tissue transglutaminase autoantibodies in patients with intestinal diseases. Journal of Autoimmunity (Suppl ): 121

Baviera, G.; Tringali, M.; Foti, M.; Magazzu', G. 1999: Tissue transglutaminase autoantibody determination in coeliac disease. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S483

Gerarduzzi, T.; Kryzak, D.; Green, P.; Bach, N.; Menon, K.; Horvath, K.; Fasano, A. 2001: Tissue transglutaminase based ELISA in primary biliary cirrhosis patients. Pediatric Research 49(4 Part 2): 121A

Chen, J.S.K.; Mehta, K. 2000: Tissue transglutaminase confers an increased sensitivity to undergo apoptosis in multidrug resistant MCF-7 human breast carcinoma cells. Proceedings of the American Association for Cancer Research 41: 244-245

Hadziselimovic, F.; Emmons, L.R.; Geneto, R.; Dahlbom, I.; Burgin Wolff, A.M. 2001: Tissue transglutaminase expression in situ during acute stage and remission of celiac disease. JPGN Journal of Pediatric Gastroenterology and Nutrition 32(3): 357

Thomazy, V.A.; Vega, F.; Medeiros, L.J.; Davies, P.J.; Jones, D. 2002: Tissue transglutaminase expression uncovers coordinate phenotypic regulation of several cell types in the paracortex of normal and neoplastic lymph nodes. Laboratory Investigation 82(1): 266A

Liu, S.L.; Wu, J.; Zhu, J.L.; Zern, M.A. 1999: Tissue transglutaminase functions as a G protein and as a cross-linking molecule in ethanol-induced inhibition of hepatocyte proliferation. Hepatology 30(4 Part 2): 337A

Ientile, R.; Campisi, A.; Teletta, M.; Raciti, G.; Vanclla, A. 2001: Tissue transglutaminase in NMDA-induced excitotoxicity. Amino Acids 21(1): 65

Haque, M.N.; Collins, J.; Thomas, P.; Santacruz, K. 2000: Tissue transglutaminase in alpha1-antitrypsin deficiency liver disease. Gastroenterology 118(4 Suppl 2 Pt 2): AASLD A144

Dore, M.P.; Naitana, A.F.; Pinna, G.G.; Sanna, S.; Mele, R.; Manca, A.; Massarelli, G.; Realdi, G. 2000: Tissue transglutaminase in gastric biopsies A marker of gastritis associated to Helicobacter pylori infection?. Gut 47(Suppl 1): A36

Nardacci, Roberta; Ciccosanti, Fabiola; Falasca, Laura; Amendola, Alessandra; Addesso, Maria; Ruco, Luigi; Fimia, Gian Maria; Antonucci, Giorgio; Ippolito, Giuseppe; Craxi, Antonio; Piacentini, Mauro; Lo Iacono, Oreste 2002: Tissue transglutaminase in hepatitis C pathogenesis. Journal of Hepatology 36(Suppl 1): 91

El Korale, A.F.; Johnson, T.; Baddour, N.M.; Elkashef, E.H.; El Nahas, A.M. 2000: Tissue transglutaminase in schistosomal nephropathy. Nephrology Dialysis Transplantation 15(9): A116

El Koraie, A.F.; Skill, N.J.; El Nahas, A.M.; Baddour, N.M.; Kashef, E.L.; Griffin, M.; Johnson, T.S. 2000: Tissue transglutaminase in the progression of human schistosomal nephropathy. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 616A

Welge Lussen, U.C.; Luetjen Drecoll, E. 2000: Tissue transglutaminase in the trabecular meshwork is inducible by TGF-beta1 and TGF-beta2. IOVS Investigative Ophthalmology and Visual Science 41(4): S503

Palosuo, K.; Nurkkala, J.; Varjonen, E.; Kalkkinen, N.; Reunala, T.; Alenius, H.T.pio 2002: Tissue transglutaminase increases binding of IgE to variant pi-5 gliadin in wheat-dependent, exercise-induced anaphylaxis. Journal of Allergy and Clinical Immunology 109(1 Suppl): S182

Parnell, N.; Martucci, S.; Daniel, Y.; Ellis, J.; O'reilly, N.; Rosen Bronson, S.; Ciclitira, P. 2001: Tissue transglutaminase increases the binding of A-gliadin 31-49, a coeliac toxic epitope, and A-gliadin 51-70, to HLA-DQ8. Gut 48(Suppl 1): A70

Coates, C.; Feighery, C.; O'keeffe, J.; Abuzakouk, M.; Whelan, A.; Weir, D.G.; Lynch, S. 1999: Tissue transglutaminase induced T cell proliferation in coeliac disease is MHC class II restricted. Immunology 98(Suppl 1): 121

Mastroberardino, Pier G.; Farrace, Maria Grazia; Rodolfo, Carlo; Oliverio, Serafina; Viti, Irene; Piredda, Lucia; Di Sano, Federica; Piacentini, Mauro 2003: Tissue transglutaminase interactors in tissue injury. Amino Acids 25(2): 200

Caputo, I.; Barone, M.V.; Troncone, R.; Auricchio, S.; Esposito, C. 2003: Tissue transglutaminase modulators regulate actin rearrangements and cell cycle in several cell types. Amino Acids 25(2): 195

Facchiano, F.; Lentini, A.; Beninati, S. 2003: Tissue transglutaminase over-expression inhibits tumor progression in vivo. Amino Acids 25(2): 198

Trapp, D.; Dieterich, W.; Wieser, H.; Leidenberger, M.; Seilmeier, D.; Hahn, E.G.; Schuppan, D. 2001: Tissue transglutaminase, the celiac disease autoantigen, preferentially generates antigenic neoepitopes in gamma and gamma but not in alpha gliadins. Gastroenterology 120(5 Suppl 1): A 684

Malamisura, B.; D'adamo, G.; Sofia, A.; Boffardi, M.; Sabatino, P. 2000: Tissue transglutaminase-specific antibodies assay versus standard serological antibodies measurements in celiac disease. JPGN 31(Suppl 3): S19

Augustine, S.D. 2001: Tissue treatment apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1250(1)

Augustine, S.D.; Leland, K.J.; Rock, J.P.; Stapf, D.E. 2003: Tissue treatment apparatus with a heater, a heat conductive bandage, and a heat-spreading means acting between the heater and bandage. Official Gazette of the United States Patent and Trademark Office Patents 1276(1)

Wadstrom, J. 2002: Tissue treatment composition comprising fibrin or fibrinogen and biodegradable and biocompatible polymer. Official Gazette of the United States Patent and Trademark Office Patents 1261(4)

Stapf, D.; Augustine, S.D.; Leland, K.J. 2003: Tissue treatment device for a limb. Official Gazette of the United States Patent and Trademark Office Patents 1271(1)

Penny, K.; Amoah, F.; Goble, N.M. 2003: Tissue treatment method. Official Gazette of the United States Patent and Trademark Office Patents 1275(1)

Bernard, K.A.; Kent, K.A.; Behr, M.J.; Shi, P.Y.; Kramer, L.D. 2003: Tissue tropism of West Nile virus in a mouse model. American Journal of Tropical Medicine and Hygiene 69(3 Suppl): 232

Szeredi,L.; Dan,A.; Palmai,N.; Ursu,K.; Balint,A.; Szeleczky,Z.; Ivanics,E.; Erdelyi,K.; Rigo,D.; Tekes,L.; Glavits,R. 2010: Tissue tropism of highly pathogenic avian influenza virus subtype H5N1 in naturally infected mute swans , domestic geese , Pekin ducks and mulard ducks. Acta Veterinaria Hungarica: 1, 133-145

Petrovska, S.; Dejanova, B.; Kandikijan, P.; Kostovska, S. 2001: Tissue type plasminogen activator and plasminogen activator type 1 in women during menopause. Clinical Chemistry and Laboratory Medicine 39(Special Suppl): S252

Raaka, S.; Huehnergarth, K.V.; Kowdley, K.V.; Bronner, M.P. 2002: Tissue typing for HFE mutations. Hepatology 35(4): 977-978

Thompson, K.H.; Tsukada, Y.; Xu, Z.; Mcneill, J.H.; Orvig, C. 2001: Tissue uptake of vanadium and its interaction with zinc, iron and copper in rats differ depending on the form of vanadium fed. FASEB Journal 15(5): A970

Kidd, K.R.; Chen, H.Y.S.; Greer, K.A.; Schwartz, M.A.; Hoying, J.B. 2003: Tissue vascularization is associated with distinct vascular gene expression patterns. FASEB Journal 17(4-5): Abstract 339

Urhausen, A.; Krieg, A.; Scharhag, J.; Kindermann, W. 2003: Tissue velocity imaging in the assessment of left ventricular function in endurance athletes vs strength athletes abusing anabolic steroids. Medicine and Science in Sports and Exercise 35(5 Suppl): S318

Ingenito, E.P. 2003: Tissue volume reduction. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)

Spiekerkoetter, U.; Tokunaga, C.; Wendel, U.; Mayatepek, E.; Vaz, F.M.; Van Vlies, N.; Ruiter, J.P.N.; Duran, M.; Ijlst, L.; Wijburg, F.A.; Wanders, R.J.A.; Strauss, A.W. 2003: Tissue, bile and blood carnitine/acylcarnitine profiles during exercise and a cold challenge with fasting in VLCAD knockout mice. American Journal of Human Genetics 73(5): 462

Coudron, T.A.; Wright, M.K.; Brandt, S.L. 2000: Tissue, molting, and hormone titer response in permissive hosts to the venom from the ectoparasite, Euplectrus comstockii. Comparative Biochemistry and Physiology Part B Biochemistry and Molecular Biology 126B(Suppl 1): S27

Komarnicki, Guenter, J.K. 2000: Tissue, sex and age specific accumulation of heavy metals by populations of the mole in a central urban area. Chemosphere 41(10): 1593-1602

Benevenga, N.J.; Haas, L.G.; Crenshaw, T.D. 2002: Tissue, sub-cellular and sub-mitochondrial location of lysine alpha-ketoglutarate reductase in piglets. Journal of Animal Science 80(Suppl 2): 61

Murciano, J.C.; Medinilla, S.P.; Eslin, D.; Poncz, M.; Cines, D.B.; Muzykantov, V.R. 2002: Tissue-Plasminogen Activator Coupling to Erythrocytes Prolongs Its Half-Life and Allows Selective Lysis of Nascent, but Not Pre-Existing Clots. Blood 100(11): Abstract No. 2759

Byerley, R.L.; Mcdaniel, B.J.; Aldrich, C.J.; Wek, R.C.; Durden, D.L.; Anthony, T.G. 2004: Tissue-Specific Alterations in mRNA Translation by the Cancer Drug L-Asparaginase. FASEB Journal 18(4-5): Abstract 827

Borovitskaya, A.E.; Harmon, J.M. 2004: Tissue-Specific Regulation of Human Glucocorticoid Receptor Expression. FASEB Journal 18(4-5): Abstract 647

Sidorova, E.; Rosen, A. 2003: Tissue-array indicates specificity of B-CLL IgM Preliminary results. Human Antibodies 12(1-2): 8-9

Rigaud, J.; Hovington, H.; Latulippe, E.; Lessard, A.; Larue, H.; Lacombe, L.; Fradet, Y. 2003: Tissue-arrays of invasive bladder cancer Validation of the technique and prognostic value of Cyclin E, p53, p21 and p27 by immunohistochemical analysis. European Urology Suppls 2(1): 68

Von Landenberg, P.; Schölmerich, J. 2000: Tissue-associated autoantigens in rheumatoid arthritis. Tissue-antigens detected by autoantibodies in synovial fluid and sera of RA patients. Clinical Reviews in Allergy and Immunology 18(1): 59-71

Greenbaum, E.; Sanders, C.A. 2003: Tissue-based standoff biosensors for detecting chemical warfare agents. Official Gazette of the United States Patent and Trademark Office Patents 1276(3)

Greenbaum, E.; Sanders, C.A. 2003: Tissue-based water quality biosensors for detecting chemical warfare agents. Official Gazette of the United States Patent and Trademark Office Patents 1270(4)

Iwata, K.K.; Stephenson, J.R.; Gold, L.I. 2003: Tissue-derived tumor growth inhibitor. Official Gazette of the United States Patent and Trademark Office Patents 1272(1)

Iwata, K.K.; Stephenson, J.R.; Gold, L.I. 2003: Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof. Official Gazette of the United States Patent and Trademark Office Patents 1270(1)

Mcllroy, B.K.; Ashton, T.; Maini, R.; Phillips, R.E. 2002: Tissue-derived vascular grafts and methods for making the same. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)

Li, F.-W.; Kuo, L.-Y.; Huang, Y.-M.; Chiou, W.-L.; Wang, C.-N. 2010: Tissue-direct PCR, a rapid and extraction-free method for barcoding of ferns. Molecular Ecology Resources 10(1): 92-95

Murakami, Y.; Takeuchi, S.; Takahashi, S. 2001: Tissue-distribution of interleukin-18 messenger RNA in the mouse. Zoological Science 18: 11

Kim, W.G.; Huh, J.H.; Lee, W.Y.; Park, J.K. 2003: Tissue-engineered acellularized valve xenografts in a pig-to-goat model. International Journal of Artificial Organs 26(7): 662

Mertsching, H.; Leyh, R.; Rebe, P.; Wilhelmi, M.; Bader, A.; Herden, T.; Oberbeck, A.; Zieme, P.; Haverich, A. 2001: Tissue-engineered autologous heart-valves Results after 3, 6, and 9 - month implantation in a sheep model. International Journal of Artificial Organs 24(8): 577

Bhargava, S.; Chapple, C.; Bullock, A.; Macneil, S. 2004: Tissue-engineered buccal mucosa In vitro contraction and stress testing. European Urology Suppls 3(2): 85

Shimizu, T.; Yamato, M.; Isoi, Y.; Kikuchi, A.; Okano, T. 2002: Tissue-engineered cardiac grafts survive and preserve their beating up to 6 months in rat subcutaneous tissues. Circulation 106(19): 2; 464

Landeen, L.K.; Kellar, R.S.; Ratcliffe, A.; Williams, S.K. 2001: Tissue-engineered constructs stimulate angiogenesis in ischemic cardiac tissue. Abstracts of Papers American Chemical Society 221(1-2): BIOT 252

Naughton, G.; Pinney, E.; Mansbridge, J.; Fitzpatrick, R. 2001: Tissue-engineered derived growth factors as a topical treatment for rejuvenation of photodamaged skin. Journal of Investigative Dermatology 117(2): 543

Zhang, Y.anyuan; Leuba, Anne Laure; Frey, Peter 1999: Tissue-engineered human urothelium for urinary tract reconstruction. Journal of Urology 161(4 Suppl): 63

Bradbury, J. 1999: Tissue-engineered kidney tried out for first time in uraemic animals. Lancet (North American Edition) 353(9163): 1501

Goh, J.C.o Hong; Chan, K.H. 2004: Tissue-engineered ligament. Official Gazette of the United States Patent and Trademark Office Patents 1282(3)

Schmidt, R.J.; Thomsen, A.R.; Schmelzeisen, R.; Sittinger, M. 2003: Tissue-engineered mineralized autologous 3D bone in maxillary sinus floor augmentation A clinical and histological report. Tissue Engineering 9(4): 850

Vacanti, M.P.; Leonard, J.L.; Dore, B.; Bonassar, L.J.; Cao, Y.; Stachelek, S.J.; Vacanti, J.P.; O'Connell, F.; Yu, C.S.; Farwell, A.P.; Vacanti, C.A. 2001: Tissue-engineered spinal cord. Transplantation Proceedings 33(1-2): 592-598

Goh, J.C.-H.; Ouyang, H.-W.; Teoh, S.-H.; Chan, C.K.C.; Lee, E.-H. 2003: Tissue-engineering approach to the repair and regeneration of tendons and ligaments. Tissue Engineering 9(Suppl 1): S31-S44

Punshon, G.; Seifalian, A.M.; Salacinski, H.J.; Krigsman, B.; Hamilton, G. 2001: Tissue-engineering of a novel poly urethane vascular graft MyoLinK. FASEB Journal 15(5): A1129

Tranquillo, R.T.; Mooradian, D.L.; Girton, T.S.; Guido, S. 2000: Tissue-equivalent rods containing aligned collagen fibrils and schwann cells. Official Gazette of the United States Patent and Trademark Office Patents 1234(1)

Yeves, R.; Miri, B.; Abraham, K.; Eyal, G.; Pierre, Y.; Shoenfeld, Y. 2000: Tissue-factor expression by endothelial cells upon exposure to anti-endothelial cell antibodies directed to different target antigens. Journal of Autoimmunity 15(2): A27

Kristjansen, Paul, E.G. 2002: Tissue-isolated tumors in mice Ex vivo perfusion of human tumor xenografts. Teicher, Beverly A Cancer Drug Discovery and Development Tumor models in cancer research 435-451

Weber, Paul J.; Weber, Michael Robert; Da Silva, Luiz B. 2004: Tissue-lifting device. Official Gazette of the United States Patent and Trademark Office Patents 1280(1)

Irons, M.B.; Tworetzky, W.; Miron, P.M.; York, S.; Bonilla, F.A.; Mcdonald, D.; Ahern, D.; De Bauche, D.M. 2003: Tissue-limited mosaicism of chromosome 22q112 deletion. Genetics in Medicine 5(3): 201

Hrycek, A.; Kokocińska, D.; Kośmider, J.; Konieczny, B. 2003: Tissue-polypeptide-specific antigen in SLE patients treated with low doses of quinagolide. Lupus 12(2): 149-152

D.Framond, Annick, J. 2000: Tissue-preferential promoters. Official Gazette of the United States Patent and Trademark Office Patents 1230(4)

Boatright, J.H.; Knox, B.E.; Stodulkova, E.; Nguyen, H.T.; Padove, S.A.; Matheu, E.A.; Borst, D.E.; Nickerson, J.M. 2001: Tissue-restricting DNA regulatory elements in the mouse IRBP promoter. IOVS Investigative Ophthalmology and Visual Science 42(4): S353

Zhang, L.; Taniguchi, T.; Zhu, J.; Muramatsu, I. 1999: Tissue-selective effects of chronic prazosin treatment on alpha1-adrenoceptor subtypes in rats. Japanese Journal of Pharmacology 79(Suppl 1): 144P

Ukai, M.; Hatanaka, T.; Ohtake, A.; Sato, S.; Miyata, K. 2003: Tissue-selective profile of YM905 for urinary bladder over salivary gland in rats. European Urology Suppls 2(1): 142

Krishnan, A.V.; Swami, S.; Peng, L.; Wang, J.; Moreno, J.; Feldman, D. 2010: Tissue-selective regulation of aromatase expression by calcitriol: implications for breast cancer therapy. Endocrinology 151(1): 32-42

Jiang, Y.H.; Bressller, J.; Liu, Q.; Beaudet, A.L. 2002: Tissue-specific DNA methylation correlates with brain-specific imprinting of the Angelman gene, UBE3A. American Journal of Human Genetics 71(4 Suppl): 168

Miyauchi, N.; Imamura, T.; Ohtani, N.; Murakami, N.; Shiota, K. 2002: Tissue-specific DNA methylation status in the upstream of mouse period 1. Biology of Reproduction 66(Suppl 1): 247

Malik, A.K.; Kowalski, J.; Ferrara, N.; Gerber, H.P.ter 2003: Tissue-specific VEGF gene ablation or systemic anti-VEGF treatment using a soluble immunoadhesin in adult mice does not interfere with physiologic hematopoiesis. Proceedings of the American Association for Cancer Research 44: 858

Osterod, M.; Hollenbach, S.; Hengstler, J.G.; Barnes, D.E.; Lindahl, T.; Epe, B. 2001: Tissue-specific accumulation of oxidative DNA base damage in repair-deficient mice. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R154

Sinogeeva, N.I.; Shavlovski, M.M.; Baranov, V.S.; Baranov, A.N.; Ostapenko, O.V.; Perevozchikov, A.P.; Dizhe, E.B.; Akif'ev, B.N.; Gaitskhoki, V.S. 2000: Tissue-specific administration of reporter genes by injecting complexes of protein conjugates with DNA. Bone Marrow Transplantation 25(Suppl 2): S127

Verhagen, A.; Kim, Y.L.; Varki, A.; Varki, N.M. 2003: Tissue-specific alterations in sialylation and sialic acid 9-O-acetylation in rats and mice Evidence for species-specific rapid evolution of sialylation phenotypes. Glycobiology 13(11): 897

Motojima, K.; Fujishiro, K.; Sato, O.; Kuriki, C.; Fukui, Y. 2000: Tissue-specific and PPAR-regulated expression of fatty acid transport-related proteins in various tissues of mouse. Biochemical Society Transactions 28(5): A393

Norris, J.; Clawson, G.; Westwater, C.; Schofield, D.; Schmidt, M.; Hoel, B.; Dolan, J.; Pan, W.H.a 2001: Tissue-specific and pathogen-specific toxic agents and ribozymes. Official Gazette of the United States Patent and Trademark Office Patents 1249(1)

Tanabe, S.; Okada, M.; Minami, E.; Shibuya, N. 2001: Tissue-specific and systemic expression of defence-related genes in rice plants in response to N-acetylchitooligosaccharide elicitor. Plant and Cell Physiology 42(Suppl): s92

Schoelch, C.; Gossel, M.; Herling, A.W. 2002: Tissue-specific antilipolysis A tissue-microdialysis study in Wistar and Zucker Fatty rats. Diabetologia 45(Suppl 2): A 229-A 230

Schoelch, C.; Gotthard, S.; Gossel, M.; Herling, A.W. 2002: Tissue-specific antilipolysis A tissue-microdialysis study in rats. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R33

Sauer, S.; Okun, J.G.; Muehlhausen, C.; Ott, N.; Feyh, P.; Langhans, C.D.; Goodman, S.I.; Ullrich, K.; Hoffmann, G.F.; Rinaldo, P.L.; Koeller, D.M.; Koelker, S. 2003: Tissue-specific biochemical analysis in GCDH-/- mice. Journal of Inherited Metabolic Disease 26(Suppl 2): 54

Milano, A.; Gonye, G.; Lankford, E.; Schwaber, J.; Hoek, J. 2002: Tissue-specific changes in gene expression patterns following chronic ethanol feeding in the rat. Alcoholism Clinical and Experimental Research 26(5 Suppl): 55A

Mcclelland, G.B.; Brooks, G.A. 2001: Tissue-specific changes in the expression of monocarboxylate transporters and LDH after chronic hypoxia. FASEB Journal 15(4): A96

Lovshin, J.; Brown, T.; Drucker, D.J. 2000: Tissue-specific control of Glucagon-Like Peptide-2 receptor expression in mice expressing a GLP-2R-LacZ transgene. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A306

Stec, D.E.; Sigmund, C.D. 1999: Tissue-specific deletion of a floxed human angiotensinogen transgene using the Cre-loxP recombinase system. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 356A

Tonks, I.; Paterson, C.; Parsons, P.; Sturm, R.; Kay, G. 2000: Tissue-specific deletion of retinoblastoma function in mice. Cell Biology International 24(12): 961

Backman, S.A.; Ghazarian, D.; Mak, T.W. 2003: Tissue-specific deletion of the tumor suppressor PTEN in mouse skin A role for PTEN in mammalian organ growth. Proceedings of the American Association for Cancer Research 44: 960

Hendrix, I.; Morris, H.A.; May, B.K. 2000: Tissue-specific distribution and regulation of CYP1. Bone (New York) 27(4 Suppl): 38S

Shimizu, Y.; Hirayama, K.; Usui, J.; Nagata, M.; Yoh, K.; Yamagata, K.; Koyama, A. 2003: Tissue-specific distribution of alternatively spliced COL4A5 isoform reflects the phenotypic variation in Alport syndrome. Journal of the American Society of Nephrology 14(Abstracts Issue): 878A

Wheeler, A.D.; Evenson, J.K.; Sunde, R.A. 2002: Tissue-specific distribution of glutathione peroxidase-1 and -4 mRNA transcripts in humans. FASEB Journal 16(5): A993

Tesarova, M.; Capkova, M.; Kaplanova, V.; Hansikova, H.; Zeman, J. 2001: Tissue-specific distribution of mtDNA mutations in 26 MERRF and MELAS patients. European Journal of Human Genetics 9(Suppl 1): P1174

Hansen, J.; Dawley, R.M.; Goddard, K.A. 2000: Tissue-specific distribution of ploidy in the unisexual minnow Phoxinus eos-neogaeus. Journal of the Pennsylvania Academy of Science 73(Suppl ): 159

Biessen, E.A.L.; Van, D.B.lt, E.; Prince, P.; Valentijn, R.; Van, D.M.rel, G.A.; Van Boom, J.H.; Van Berkel, T.J.C. 1999: Tissue-specific down-regulation of microsomal triglyceride transfer protein by glycoconjugated PNA. Circulation 100(18): I815-I816

Oakes, N.; Kjellstedt, A.; Thalen, P.; Wettesten, M.; Lofgren, L.; Ljung, B. 2001: Tissue-specific effects of AZ 242, a novel PPARalpha/gamma agonist, on glucose and fatty acid metabolism in obese Zucker rats An in vivo simultaneous multi-tracer assessment. Diabetes 50(Suppl 2): A121-A122

Wong, R.J.; Mizobuchi, M.; Zhao, H.; Abate, A.; Vreman, H.J.; Contag, C.H.; Stevenson, D.K. 2004: Tissue-specific effects of dexamethasone on heme oxygenase-1 expression. FASEB Journal 18(4-5): Abstract 858

Yan, W.; Ryan, P.L.; Bagnell, C.A. 2002: Tissue-specific effects of relaxin on the reproductive tract of neonatal pigs Estrogen receptor-dependent and -independent actions. Biology of Reproduction 66(Suppl 1): 179

Kenney, J.S.; Senda, M.; Goetzi, E.J. 1999: Tissue-specific endothelial differentiation gene receptor protein expression probed with EDG-receptor antibodies. FASEB Journal 13(4 Part 1): A463

Matsuzaki, Y.; Li, K.; Nakano, A.; Aho, S.; Pulkkinen, L.; Uitto, J. 2002: Tissue-specific expression and transcriptional modulation of human ABCC6, the gene mutated in pseudoxanthoma elasticum. Journal of Investigative Dermatology 119(1): 264

Guo, W.J.; Bundithya, W.; Goldsbrough, P. 2002: Tissue-specific expression of Arabidopsis metallothionein genes during development and in response to copper. Plant Biology (Rockville) : 153

Bassett, C.; Callahan, A.; Scorza, R.; Srinivasan, C. 2003: Tissue-specific expression of GUS in tomato under the control of a type II chlorophyll a/b-binding protein promoter from peach. HortScience 38(5): 710

Egbert, T.; Marchbank, A.; Dellavalle, R.; Degregori, J.; Su, L.J.; Walsh, P.; Lee, L. 1999: Tissue-specific expression of KET and its splicing variant CUSP, members of the P53 family. Journal of Investigative Dermatology 112(4): 590

Ma, L.; Yang, H.; Long, P.; Davidson, J.; Pratt, S.; Sandusky, G.; Dantzig, A.; Slapak, C. 2003: Tissue-specific expression of MRP3 and MRP5 genes in non-small cell lung cancer. Proceedings of the American Association for Cancer Research 44: 735

Boukouvala, S.; Sim, E. 2000: Tissue-specific expression of arylamine N-acetyltransferases in mice. Biochemical Society Transactions 28(5): A200

Kadenbach, B.; Frank, V.; Linder, D.; Arnold, S.; Exner, S.; Huettemann, M. 1999: Tissue-specific expression of cytochrome c oxidase isoforms and role in nonshivering thermogenesis. Papa, S, Guerrieri, F, Tager, J M Frontiers of cellular bioenergetics: Molecular biology, biochemistry, and physiopathology 621-633

Bojunga, J.; Dresar, B.; Kusterer, K.; Sterner Kock, A.; Konrad, T.; Usadel, K.H.nning 2001: Tissue-specific expression of endothelial and inducible nitric oxide synthase and oxidative stress in streptozotocin-induced diabetic rats. Diabetes 50(Suppl 2): A148-A149

Shao, X.; Johnson, J.; Somlo, S.; Igarashi, P. 2001: Tissue-specific expression of green fluorescent protein and Cre recombinase in the developing kidney and GU tract. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 526A

Krieglstein, C.F.; Stokes, K.Y.; Russell, J.M.; Grisham, M.B.; Granger, D.N.il 2001: Tissue-specific expression of inducible nitric oxide synthase and its influence on experimental colitis. FASEB Journal 15(5): A831

Tremblay, L.O.; Herscovics, A. 2002: Tissue-specific expression of mammalian Golgi class I alpha1,2-mannosidases involved in N-glycan processing. FASEB Journal 16(5): A1178

Lay, J.M.; Chen, X.; Petry, M.; Schonhoff, S.; Leiter, A.B.; Samuelson, L.C. 2000: Tissue-specific expression of mouse cholecystokinin gene constructs in transgenic mice. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A294

Aho, S.; Aho, M.; Rodeck, U.; Reynolds, A.; Uitto, J. 2000: Tissue-specific expression of p120ctn catenin isoforms. Journal of Investigative Dermatology 114(4): 851

Chen, Y.; Moeckel, G.; Xiong, H.; Liang, D.; Wu, G. 2002: Tissue-specific expression patterns of Pkhd1 during mouse development. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 112A

E.S.ehawi, A.M.; Hedgcoth, C. 2001: Tissue-specific gene expression in wheat. FASEB Journal 15(4): A541

Ohya, S.; Kimura, S.; Asakura, K.; Watanabe, M.; Imaizumi, Y. 2000: Tissue-specific gene expression of erg and KCNQ subfamilies in rat smooth muscles. Japanese Journal of Pharmacology 82(Suppl 1): 135P

Suzuki, T.; Takahashi, T.; Yamasaki, A.; Fujiwara, T.; Hirakawa, M.; Akagi, R. 2000: Tissue-specific gene expression of heme oxygenase-1 and non-specific delta-aminolevulinate synthase in a rat model of septic multiple organ dysfunction syndrome. Biochemical Pharmacology 60(2): 275-283, 15 July

Kino, T.; Chrousos, G.P. 2002: Tissue-specific glucocorticoid resistance-hypersensitivity syndromes: multifactorial states of clinical importance. Journal of Allergy and Clinical Immunology 109(4): 609-613

Franz, J.; Weingartner, B.; Unterbeck, A.; Rae, P. 2001: Tissue-specific human neuronal calcium channel subtypes and their use. Official Gazette of the United States Patent and Trademark Office Patents 1246(2)

Principato, M.; Grenade, C.; Weaver, J.; Osborne, R.; Robl, M. 1999: Tissue-specific immune responsiveness to staphylococcal enterotoxin in the aged gut-associated lymphatics. FASEB Journal 13(4 Part 1): A291

Tumanov, A.V.; Kuprash, D.V.; Lagarkova, M.A.; Stewart, C.L.; Nedospasov, S.A. 2000: Tissue-specific inactivation of LT-beta gene in B cells. FASEB Journal 14(6): A1149

Vejares, S.González.; Sabat, P.; Sanchez-Hernandez, J.C. 2010: Tissue-specific inhibition and recovery of esterase activities in Lumbricus terrestris experimentally exposed to chlorpyrifos. Comparative Biochemistry and Physiology. Toxicology and Pharmacology: Cbp 151(3): 351-359

Alfonso Jaume, M.A.; Pollock, A.S.; Steiman, K.; Mcneil Cape, L.; Lovett, D.H. 2001: Tissue-specific interactions of the gelatinase A enhancer, RE-1, and the first intron regulate developmental expression of gelatinase A in transgenic mouse. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 699A

Long, F.; Zhang, X.; Mcmahon, A.P. 2001: Tissue-specific knockout of smoothened reveals a critical role for Hedgehog signaling in chondrocyte proliferation. Developmental Biology 235(1): 198

Rountree, R.B.; Schoor, M.; Marks, M.; Mishina, Y.; Kingsley, D. 2001: Tissue-specific knockout shows that BMP signaling is required for articular cartilage maintenance in vertebrate joints. Developmental Biology 235(1): 256

Walters, K.; Corbin, J.; Anderson, G.; Roser, J.; Conley, A. 1999: Tissue-specific localization of aromatase in the equine embryo by in situ hybridization and immunocytochemistry. Biology of Reproduction 60(Suppl 1): 157

Hryshko, L.V. 2002: Tissue-specific modes of Na/Ca exchanger regulation. Annals of the new York Academy of Sciences 976: 166-175

Schnitzer, J.E. 2001: Tissue-specific monoclonal antibodies. Official Gazette of the United States Patent and Trademark Office Patents 1248(1)

Kucia, M.; Ratajczak, J.; Janowska Wieczorek, A.; Ratajczak, M. 2003: Tissue-specific muscle, neural and liver stem/progenitor cells reside in the bone marrow, respond to an SDF-1 gradient and are mobilized into peripheral blood during stress and tissue injury A new perspective on stem cell plasticity. Experimental Hematology (New York) 31(7 Suppl 1): 133-134

Andreyev, A.; Fiskum, G. 1999: Tissue-specific pathways of cytochrome c release from mitochondria. Biophysical Journal 76(1 Part 2): A271

Schneider, Mark; Galton, Valerie Anne; Wasco, Emily; Martinez, Elena; St Germain, Donald L. 2000: Tissue-specific patterns of deiodinase expression. Endocrine Journal 47(Suppl August): 82

Pendina, A.; Chiryaeva, O.; Kuznetzova, T.; Baranov, V. 2003: Tissue-specific peculiarities methylation pattern of metaphase chromosomes in human embryonic and extraembryonic cells detected by nick-translation in situ. Annales de Genetique 46(2-3): 287-288

Thim, L.; Clausen, J.T.; Kristensen, P.; Nielsen, P.F.; Wulff, B.S. 2000: Tissue-specific processing of cocaine- and amphetamine-regulated transcript peptides in the rat. Regulatory Peptides 94(1-3): 75, 25 October

Surai, P.F.; Mcdevitt, R.M.; Speake, B.K.; Noble, R.C.; Sparks, N.H.C. 1999: Tissue-specific profiles of docosahexaenoic acid in male chickens depends on the dietary provision. Proceedings of the Nutrition Society 58(1): 30A

Okada, Y.kio; Yoshigi, Naohiro; Ito, Kazutoshi; Kihara, Makoto 1999: Tissue-specific promoter. Official Gazette of the United States Patent and Trademark Office Patents 1226(2)

Chango, A.; Pogribny, I.P.; Pogribna, M.; James, J.S. 2001: Tissue-specific promoter methylation and expression in the reduced folate carrier gene. FASEB Journal 15(5): A736

Van Der Woude, F.J. 2000: Tissue-specific reactivity against renal allografts. Immunology 101(Suppl 1): 68

IIda, K.; Del Rincon, J.P.; Kim, D.S.; Itoh, E.; Coschigano, K.T.; Kopchick, J.J.; Thorner, M.O. 2004: Tissue-specific regulation of GH receptor and IGF-I in the pituitary and liver of transgenic mice that express GH or a GH antagonist and of GH deficient mice. Growth Hormone and IGF Research 14(2): 130

Strassburg, C.P.; Nguyen, N.; Strassburg, A.; Topp, J.; Li, Q.; Barut, A.; Obermayer Straub, P.; Manns, M.P.; Tukey, R.H. 2000: Tissue-specific regulation of UGT in the human hepato-gastrointestinal Role in immunosuppressant glucuronidation. Drug Metabolism Reviews 32(Suppl 1): 22

Jones, D.E.; Cui, D.; Roque, M.A. 1999: Tissue-specific regulation of c-myc transcription following partial hepatectomy in transgenic mice. Proceedings of the American Association for Cancer Research 40: 365

Wang, Y.; Watford, M. 2004: Tissue-specific regulation of glutamine synthetase expression. FASEB Journal 18(4-5): Abstract 370

Lai, K.; Presley, C.A.; Langley, S.D.; Elsas, L.J. 1999: Tissue-specific regulation of human galactose-1-phosphate uridyltransferase. American Journal of Human Genetics 65(4): A425

Bush, J.A.; Li, G. 2002: Tissue-specific regulation of the murine ABCB1 homologue by p53. Proceedings of the American Association for Cancer Research 43: 1107

Kappen, C.; Yaworsky, P.J. 2001: Tissue-specific regulatory elements. Official Gazette of the United States Patent and Trademark Office Patents 1251(3)

Yamagishi, H.; Maeda, J.; Hu, T.; Mcanally, J.; Yamagishi, C.; Srivastava, D. 2002: Tissue-specific regulatory elements of Tbx1, a del 22q11 candidate gene, reveal a molecular cascade involved in pharyngeal arch development. Circulation 106(19): II203

Lavoie, J.L.; Bruse, K.D.; Sigmund, C.D. 2002: Tissue-specific renin-angiotensin system in the proximal tubule. FASEB Journal 16(4): A423

Yu, D.C.; Ho, K.; Kimball, L.; Ramesh, N.; Dilley, J.; Chen, Y.; Kirn, D.; Borellini, F.; Ando, D. 2003: Tissue-specific replicating oncolytic adenoviruses replicate in vivo in humans without the appearance of wild type adenovirus. Cancer Gene Therapy 10(Suppl 1): S14

Bush, J.A.; Nguyen, H.V.; Suryawan, A.; O'connor, P.M.J.; Burrin, D.G.; Reeds, P.J.; Liu, C.W.; Davis, T.A. 2001: Tissue-specific response of protein metabolism to somatotropin treatment in growing pigs. FASEB Journal 15(5): A730

Stipanuk, M.H.; Hirschberger, L.L.; Londono, M.; Hu, M.Y.; Lee, J.I. 2001: Tissue-specific responses to increases in dietary protein or sulfur amino acids. FASEB Journal 15(4): A267

Takayama, S.; Homma, S.; Reed, J.C.; Gotz, R.; Wiese, S.; Rossoll, W.; Schweizer, U.; Berzaghi, M.; Jablonka, S.; Holtmann, B.; Rapp, U.; Sendtner, M. 2003: Tissue-specific roles of BAG1 and BAG3 in apoptosis suppression in vivo. Proceedings of the American Association for Cancer Research 44: 1218-1219

Curiel, D.T.; Reynolds, P.N. 2004: Tissue-specific self-inactivating gene therapy vector. Official Gazette of the United States Patent and Trademark Office Patents 1281(1)

Buggs, R.J.A.; Elliott, N.M.; Zhang, L.; Koh, J.; Viccini, L.F.; Soltis, D.E.; Soltis, P.S. 2010: Tissue-specific silencing of homoeologs in natural populations of the recent allopolyploid Tragopogon mirus. New Phytologist 186(1): 175-183

Dirksen, W.P.; Joyce, K.; Fisher, S.A. 2001: Tissue-specific splicing of a myosin phosphatase targeting subunit 1 alternative exon is regulated by intronic cis-elements and a potentially novel exonic splicing enhancer. FASEB Journal 15(5): A900

Esterbauer, H.; Oberkofler, H.; Krempler, F.; Patsch, W. 2000: Tissue-specific transcript initiation and splicing of human uncoupling protein-3. International Journal of Obesity 24(Suppl 1): S22

Broxmeyer, H.E.; Cooper, S.; Hangoc, G.; Kim, C.H. 2000: Tissue-specific transgene expression of chemokine CKbeta-11 is coincident with enhanced levels of cycling macrophage progenitors in spleen. Experimental Hematology 28(7 Suppl 1): 99-100

Hurwitz, D.; Yoshida, M.; Richardson, S.; Moreno, R.; Fuhlbrigge, R.; Rich, B.; Blumberg, R.; Kupper, T. 2003: Tissue-specific tumor immunity is mediated by trafficking-related molecules fucosyl transferase VII and b7 integrin. Journal of Investigative Dermatology 121(1): 0962

Tiukinhoy, S.D.; Nagaraj, A.; Klegerman, M.E.; Kane, B.J.; Macdonald, R.C.; Matsumura, J.S.; Mcpherson, D.D. 1999: Tissue-targeted acoustic cationic liposomes Potential for directed gene delivery. Circulation 100(18): 1; 444

Tiukinhoy, S.; Nagaraj, A.; Kane, B.; Klegerman, M.; Macdonald, R.; Matsumura, J.; Mcpherson, D. 1999: Tissue-targeting of acoustic cationic liposomes Potential for directed gene delivery. Journal of Investigative Medicine 47(7): 242A

Schmidt, E.; Reimer, S.; Marinkovich, M.P.; Broecker, E.B.; Zillikens, D. 2000: Tissue-type but not urokinase-type plasminogen activator is released after treatment of cultured normal human keratinocytes with autoantibodies to bullous pemphigoid antigen BP180. Journal of Investigative Dermatology 115(3): 534

Cao, M.; Sahmi, M.; Lussier, J.G.; Price, C.A. 2002: Tissue-type plasminogen activator and protease nexin-1 expression by bovine granulosa cells in vitro. Biology of Reproduction 66(Suppl 1): 213

Chernicky, C.L.; Yi, L.; Tan, H.; Ilan, J. 2005: Tissue-type plasminogen activator is upregulated in metastatic breast cancer cells exposed to insulin-like growth factor-i. Clinical Breast Cancer 6(4): 340-348

Reventos, Jaume; Segovia, Alba E.; De Torres, Ines; Morote, Juan; Paciucci, Rosanna 2003: Tissue-type plasminogen activator, PAI-1 and urokinase receptor are overexpressed in prostate carcinoma and benign prostate hyperplasia PAI-1 levels correlate with invasive tumors. Journal of Urology 169(4 Suppl): 160

Chang, Y.ng Nien; Hallenbeck, Paul, L.; Hay, Carl, M.; Stewart, David, A. 2003: Tissue-vectors specific replication and gene expression. Official Gazette of the United States Patent and Trademark Office Patents 1275(4)

Abe, T.; Sekiguchi, O.; Kearns, C.F.; Aoba, T.; Matsumoto, T. 2003: Tissue/organ-level body composition in male college Olympic-weightlifters. Medicine and Science in Sports and Exercise 35(5 Suppl): S324

Kaplan, D.H.; Anderson, B.E.; Shlomchik, W.; Shlomchik, M. 2002: Tissues affected by graft-vs-host disease vary with MHC haplotype in MHC-matched, MiHA-incompatable murine models. Journal of Investigative Dermatology 119(1): 309

Alio, J.L.; Mulet, M.E.; Gomez, J.J.; Alvarez, R.; Guerra, R.M. 1999: Tisuacryl A new generation of the N-butyl cyanocrilate adhesive. IOVS Investigative Ophthalmology and Visual Science 40(4): S857

Tzeng, S.J.; Huang, J.D. 2003: Tisuue specific regulation of rat Mrp3 gene in hepatoma cells. FASEB Journal 17(4-5): Abstract 646

Mcdonald, G.D. 2002: Titan and prebiotic chemistry. Astrobiology 2(4): 438

Trimboli, J.A.; Dutta, P.K. 2003: Titania-based hydrocarbon sensor with internal zeolite filter for harsh environments. Abstracts of Papers American Chemical Society 225(1-2): ANYL 258

Nuss, M.; Kallies, A. 2001: Titanio caradjae comb n, transferred from Brachodidae to Crambidae. Nota Lepidopterologica 24(3): 33-39

O'neil, G.W.; Phillips, A.J. 2004: Titanium -mediated cyclization of enynes a synthesis of the C9-C19 subunit of dictyostatin-1. Tetrahedron Letters 45(22): 4253-4256

Dearnaley, G.; Peacock, A.T.omas 2001: Titanium alloy hip prosthesis. Official Gazette of the United States Patent and Trademark Office Patents 1251(4)

Stinson, J.S.; Clerc, C.O.; Mayer, D.W. 1999: Titanium alloy self-expanding stent. Official Gazette of the United States Patent and Trademark Office Patents 1220(5): 4367

von Knoch, M.; Saxler, G.; Quint, U. 2004: Titanium as an implant material for rods of transpedicular instrumentation of the lumbar spine. Biomedizinische Technik. Biomedical Engineering 49(5): 132-136

Boeckmann, J.; Lahl, H.; Eckert, T.; Unterhalt, B. 2000: Titanium blood levels in dialysis patients compared to that of healthy volunteers. Pharmazie 55(6): 468

Sartori, R.H.; Diez, S.; Navarrete, E.; Sariego, R.; Moya, S.A.; Carusso, F.; Rodriguez, S. 1999: Titanium complex with diketonate ligands Application and effect as antitumoral drug. Abstracts of Papers American Chemical Society 218(1-2): MEDI 46

Meléndez, E. 2002: Titanium complexes in cancer treatment. Critical Reviews in Oncology/Hematology 42(3): 309-315

Hartmann, W.; Kerner, D. 2002: Titanium dioxide powder which contains iron oxide. Official Gazette of the United States Patent and Trademark Office Patents 1259(3)

Summer, B.T.; Barnstorf, S.; Sander, C.A.; Przybilla, B.; Thomas, P. 2001: Titanium implant hypersensitivity reflected by retarded fracture healing, eczema and T-cell hyperresponsiveness in vitro. Allergy 56(Suppl 68): 136

Schwietert, C.W.; Gerber, N.C.; Mccue, J.P. 1999: Titanium inhibition of Jensen sarcoma. FASEB Journal 13(7): A1538

Davidson, J.A. 1999: Titanium molybdenum hafnium alloys for medical implants and devices. Official Gazette of the United States Patent and Trademark Office Patents 1226(3)

Caussin, C.; Alibelli, M.J.; Elbaz, M.; Hamon, M.; Grollier, G.; Commeau, P.; Lancelin, B. 2003: Titanium nitride-oxide coated stent Six-month angiographic and intravascular ultrasound follow-up. Journal of the American College of Cardiology 41(6 Suppl A): 7A

Caussin, C.; Hamon, M.; Carrie, D.; Commeau, P.; Grollier, G.; Puel, J.; Lancelin, B. 2002: Titanium nitride-oxyde coated stent First implantations in humans and six months angiographic follow-up. Circulation 106(19): II520-II521

Fritz, E.A.; Glant, T.T.; Jacobs, J.J.; Roebuck, K.A. 2002: Titanium particles activate IL-8 and MCP-1 chemokine genes in human osteoblasts. FASEB Journal 16(4): A724

Shukla, N.K.S.; Deo, S.V.S.; Kar, M. 2002: Titanium plate suspension A new technique of reconstruction following hemimandibulectomy for oral cancer. International Journal of Cancer Suppl (13): 260

Lehle, K.; Buttstaedt, J.; Preuner, J.G.; Birnbaum, D.E. 2002: Titanium-coated polymers for direct cell seeding Toxicological investigations on a Patient-specific endothelial cell culture. Naunyn-Schmiedeberg's Archives of Pharmacology 365(Suppl 1): R156

Nishihama, S.; Shio, S. 2002: Titanium-silica complex and cosmetic preparation compounding the same. Official Gazette of the United States Patent and Trademark Office Patents 1256(3)

Curry Rogers, Kristi 2002: Titanosaur tails tell two tales A second Malagasy Titanosaur with saltasaurid affinities. Journal of Vertebrate Paleontology 22(3 Suppl): 47A-48A, 19 September

Lohmann, T.; Kellner, K.; Verlohren, H.J.; Krug, J.; Steindorf, J.; Seissler, J. 2001: Titer and combination of islet cell autoantibodies discriminate two types of latent autoimmune diabetes in adults. Diabetologia 44(Suppl 1): A 154

Sebastian, A.; Chapman, K.; Carlson, J.; Sigle, G.; Wright, H.; Gurakar, A.; Pennington, S.; Smith, D.; Nour, B. 2000: Titer based dosing of hepatitis B immuneglobulin produces equivalent results in the passive immunoprophylaxis of hepatitis B with lower cost. Hepatology 32(4 Pt 2): 596A

Morley, J.E. 2000: Tithonusism Is it reversible?. Morley, John E , van den Berg, Lucretia Contemporary Endocrinology; Endocrinology of aging 127-149

Ferrari, Stephen F.; Iwanaga, Simone; Messias, Mariluce R.; Ramos, Eleildon M.; Ramos, Paulo C.S.; Da Cruz Neto, Ernesto H.; Coutinho, Paulo E.G. 2000: Titi monkeys in the Brazilian state of Rondonia. Primates 41(2): 229-234

Trinick, J.; Tskhovrebova, L. 1999: Titin: a molecular control freak. Trends in Cell Biology 9(10): 377-380

LeWinter, M.M. 2000: Titin: the "missing link" of diastole. Journal of Molecular and Cellular Cardiology 32(12): 2111-2114

Ma, K.; Gutierrez Curz, G.; Wang, K. 2004: Titin as a giant signaling molecule in the SH3 pathway Interaction of SH3 domain with the proline-rich titin PEVK segment. Biophysical Journal 86(1): 570a-571a

Mutungi, G. 2002: Titin expression in adult and neonatal rat fast and slow twitch muscles. Pfluegers Archiv European Journal of Physiology 443(Suppl 1): S191

Trombitas, K.; Greaser, M.; Labeit, S.; Jin, J.P.; Granzier, H. 1999: Titin extensibility in human soleus muscle fibers Stability of Ig domains and non-uniformity of PEVK segment extension. Biophysical Journal 76(1 Part 2): A31-A31

Rankinen, T.; Rice, T.; Boudreau, A.; Leon, A.S.; Skinner, J.S.; Wilmore, J.H.; Rao, D.C.; Bouchard, C. 2003: Titin is a candidate gene for stroke volume response to endurance training: the HERITAGE Family Study. Physiological Genomics 15(1): 27-33

Cazorla, O.F.; Granzier, H. 2001: Titin is a modulator of length-dependent activation of mouse cardiac myocytes. Biophysical Journal 80(1 Part 2): 262a-263a

Gerull, B.; Sasse Klaassen, S.; Atherton, J.; Probst, S.; Mcnabb, M.; Frenneaux, M.; Granzier, H.; Labeit, S.; Thierfelder, L. 2003: Titin mutations in dilated cardiomyopathy Evidence for cardiac but not skeletal muscle haploinsufficiency in a I-band truncation mutation and further genetic heterogeneity. Circulation 108(17): IV83

Gerull, B.; Gramlich, M.; Atherton, J.; Mcnabb, M.; Seidman, J.G.; Seidman, C.; Granzier, H.; Labeit, S.; Frenneaux, M.; Thierfelder, L. 2001: Titin mutations in familial dilated cardiomyopathy. Circulation 104(17): 2; 135

Aarli, J.A. 2001: Titin, thymoma, and myasthenia gravis. Archives of Neurology 58(6): 869-870

Makarenko, I.; Dussel, R.; Leake, M.C.; Neagoe, C.; Hajjar, R.J.; Linke, W.A. 2004: Titin-isoform shift in failing DCM hearts reduces myofibrillar passive stiffness but is independent of hypertrophy signals. Biophysical Journal 86(1): 207a

Ahmad, I.; Owens, D.; Ahmed, W.; Khan, H.; Anderson, G. 1999: Title ERCP in a district general hospital, success and complication rate. Gut 44(Suppl 1): A9

Kelley, L.P.; Kinsella, B.T.erese 2001: Title Prostaglandin D2 receptor -mediated desensitization of the alpha isoform of the human thromboxane A2 receptor. FASEB Journal 15(4): A219

Cid, J.; Ortin, X.; Elies, E.; Contreras, E.; Parra, R.; Martin Vega, C. 2002: Title The use of the direct antiglobulin test in a hospital setting. Vox Sanguinis 83(Suppl 2): 57

Ahmad, I.; Owens, D.; Ahmed, W.; Khan, H.; Walker, M.; Anderson, G. 1999: Title To assess the quality of life and symptoms in chronic hepatitis C virus infection in the absence of cirrhosis. Gut 44(Suppl 1): A54

Grim, C. 2000: Title leptin and blood pressure in hypertensive African Americans. Journal of Hypertension 18(Suppl 4): S143

Kotze, L.M.S.; Utiyama, S.R.R.; Nisihara, R.N.; Ioshii, S.O. 2000: Titles of antiendomysium antibodies and histological changes of the duodenal mucosa in Brazilian patients with celiac disease. American Journal of Gastroenterology 95(9): 2505

Witt, R.; Vaitkevicius, H.; Lockette, W. 1999: Titratable acid excretion is diminished during exercise. Medicine and Science in Sports and Exercise 31(5 Suppl): S374

Wright, C. 2004: Titratable dosage transdermal delivery system. Official Gazette of the United States Patent and Trademark Office Patents 1278(4)

Matonhodze, B.; Alfirevic, Z.; Hofmeyr, J.; Campbell, L.; Brocklehurst, P. 2000: Titrated oral misoprostol for labour induction A random allocation trial. Journal of Obstetrics and Gynaecology (Abingdon) 20(Suppl 1): S19

Franklin, B.A.; Lee, I.Min; Swain, D.P. 2002: Titrating the exercise intensity Changing paradigms and perceptions. Medicine and Science in Sports and Exercise 34(5 Suppl): S245

Marthas, M.L.; Lu, D.; Penedo, M.C.T.; Hendrickx, A.G.; Miller, C.J. 2002: Titration of a SIVmac251 stock by vaginal inoculation of Indian- and Chinese-origin rhesus macaques Transmission efficiency, viral loads and antibody responses. Journal of Medical Primatology 31(4-5): 260

Luzier, A.; Antell, L.A.; Chang, L.L.; Xuan, J.; Roth, D.A. 2001: Titration of beta-blockers in heart failure patients. Circulation 104(17): 2; 717-II 718

Pomroy, W.E.; Hart, S.P.; Min, B.R. 2002: Titration of efficacy of ivermectin and moxidectin against an ivermectin-resistant Haemonchus contortus derived from goat in the field. Journal of Animal Science 80(Suppl 2): 30

Pomroy, W.E.; Hart, S.P.; Min, B.R. 2004: Titration of efficacy of ivermectin and moxidectin against an ivermectin-resistant Haemonchus contortus derived from goats in the field. New Zealand Journal of Zoology 31(1): 95-96

Bercu, B.B. 2002: Titration of growth hormone dose using insulin-like growth factor-1 measurements: is it feasible in children?. Journal of Pediatrics 141(5): 601-605

Frisch, C.; Knappik, A.; Choidas, M.; Tesar, M. 2000: Titration of infective and noninfective Ff filamentous bacteriophages using a monoclonal antibody against g3p. Biotechniques 29(1): 26-28; 30

Wong, J.; Song, D.; Chung, F.; Blanshard, H.; Grady, D. 1999: Titration of isoflurane using BIS index improves recovery profiles in elderly patients undergoing orthopedic surgeries. Anesthesiology 91(3A): A610

Mena, J.A.; Ramírez, O.T.; Palomares, L.A. 2003: Titration of non-occluded baculovirus using a cell viability assay. Biotechniques 34(2): 260

Hill, G.M.; Carter, S.D.; Ewan, R.C.; Mahan, D.C.; Miller, P.S.; Shurson, G.C.; Veum, T.L. 1999: Titration of pharmacological doses of zinc in the nursery pig. Journal of Animal Science 77(Suppl 1): 177

Thompson, J.; Coon, E.; Mack, H.; Kuller, L.; Anderson, D.; Grant, R.; Morton, W.R.; Agy, M.B. 1999: Titration of the acutely pathogenic SHIV229 in Macaca nemestrina. Journal of Medical Primatology 28(4-5): 295

Kissinger, G.L.; Toex, U.; Selzer, S.; Laue, O.; Steffen, H.M.; Goeser, T. 1999: Titration of the antiviral interferon-alpha-2a effect with a daily intravenous high dose therapy in patients with chronic hepatitis C. Hepatology 30(4 Part 2): 371A

Goff, J.P.; Brown, T.F.; Stokes, S.R.; Brawley, C.L.; Valdez, F.R. 2002: Titration of the proper dose of calcium propionate to be included in an oral drench for fresh cows. Journal of Dairy Science 85(Suppl 1): 189

Kobayashi, N.; Takahashi, K.; Takayanagi, K.; Arai, O.; Tadano, T.; Kisara, K.; Kinemuchi, H. 2000: Titration of tissue-bound semicarbazide-sensitive amine oxidase in guinea pig with 2-bromoethylamine. Japanese Journal of Pharmacology 82(Suppl 1): 102P

Gillett, H.R.; Freeman, H.J. 1999: Titres of IgA antibody to tissue transglutaminase correlate with severity of mucosal lesion in celiac disease. Gastroenterology 116(4 Part 2): A882

Radzicki, G.; Hejduk, J.; Banbura, J. 1999: Tits preying upon hibernating bats. Ornis Fennica 76(2): 93-94

Dudlak, C.S.; Jerng, H.H.; Gilly, W.F. 2000: Tityustoxin block of native and cloned squid potassium channels is pH-dependent. Biophysical Journal 78(1 Part 2): 97A

Langburt, W.; Chez, M.G.; Krasne, V.; Buchanan, C.P. 2002: Tizanadine hydrochloride is an effective hypnotic for routine electroencephalography. Epilepsia 43(Suppl 7): 81

Lake, A.E.IIi; Saper, J.R.; Winner, P.; Spierings, E.L.H.; Cantrell, D.T.C.; White, J.R.; Cross, V.J. 2002: Tizanidine HCl in the prophylaxis of chronic daily headache Double-blind, placebo-controlled outcome study. Neurology 58(7 Suppl 3): A171-A172

Adamson, L.A.; Spiller, H.A.; Bosse, G.M. 2003: Tizanidine exposure. Journal of Toxicology. Clinical Toxicology 41(5): 664

Diamond, S.; Freitag, F.; Diamond, M.L.; Urban, G.; Pepper, B. 2000: Tizanidine in the preventative treatment of chronic tension-type headache. Cephalalgia 20(4): 335

Warner, J.S. 2003: Tizanidine is not a cure for chronic daily headache. Headache 43(3): 296; Author Reply 296-7

Sundaram, S.; Gewirtz, D.A. 1999: Tk;2EB 1089 radiosensitizes breast tumor cells. Proceedings of the American Association for Cancer Research 40: 144-145

Huang, J.; Jiang, X.; Mcdevitt, D.; Van Horn, S. 2001: TktA. Official Gazette of the United States Patent and Trademark Office Patents 1245(4)

Chalker, A.F.; Haataja, S.J.; Holden, D.W.; Holmes, D.J.; Ingraham, K.A.; Lau, G.W.; Marra, A.; Lonetto, M.A.; Mcdevitt, D.; Ray, J.; Yu, J. 2001: TktA from Streptococcus pneumoniae. Official Gazette of the United States Patent and Trademark Office Patents 1253(1)

Korotkov, S.M.; Brailovskaya, I.V. 2001: Tl+ stimulated univalent cation permeability of the inner membrane of rat liver. Doklady Akademii Nauk 378(1): 103-107

Nakajima, K.; Kawano, M.; Nagamine, H.; Ohtake, H.; Watanabe, G.; Michigishi, T.; Tonami, N. 2003: Tl-201 muscle perfusion scan with intraarterial infusion of Prostaglandin-E1 to evaluate therapeutic angiogenesis for severely ischemic limbs. Journal of Nuclear Medicine 44(5 Suppl): 58P-59P

Fukuzawa, S.; Ozawa, S.; Sugioka, J.; Inagaki, M. 1999: Tl-201/I-123 BMIPP dual SPECT to predict recovery of wall motion early after myocardial infarction Relation with low dose dobutamine echocardiography. Journal of Nuclear Medicine 40(5 Suppl): 164P

Beutler, B. 2000: Tlr4: central component of the sole mammalian LPS sensor. Current Opinion in Immunology 12(1): 20-26

Dempcy, R.O.; Gall, A.A.; Lokhov, S.G.; Afonina, I.A.; Singer, M.J.; Kutyavin, I.V.; Vermeulen, N.M.J. 2004: Tm leveling methods. Official Gazette of the United States Patent and Trademark Office Patents 1278(4)

Slovin, S.F.; Ragupathi, G.; Olkiewicz, K.; Tilak, J.; Terry, K.; Moore, K.; Fazzari, M.; Jakubowiak, J.; Lu, L.; Livingston, P.O.; Danishefsky, S.; Scher, H.I. 2000: Tn-cluster -KLH/PAM vaccine conjugates in biochemically relapsed prostate cancer Phase I trial results. Proceedings of the American Association for Cancer Research 41: 633-634

Reznikoff, W.S. 2002: Tn5 transposition. Craig, Nancy L Author, Craigie, Robert Author, Gellert, Martin Author, Lambowitz, Alan M Author Mobile DNA II 403-422

Rowan, K.; Orsetti, J.; Atkinson, P.W.; O'brochta, D.A. 2003: Tn5-mediated transformation of Aedes aegypti. American Journal of Tropical Medicine and Hygiene 69(3 Suppl): 444

Vedantam, G.; Hecht, D.W. 1999: Tn5520 and LV23 Studies of the smallest bacterial mobilizable transposon from Bacteroides fragilis and its host strain. Abstracts of the General Meeting of the American Society for Microbiology 99: 7

Peters, J.E. 2014: Tn7. Microbiology Spectrum 2(5)

Luo, Y.; Davis, J.; Tikunova, S.; Smillie, L.B.; Rall, J.A. 2001: TnC mutants influence relaxation in skeletal muscle in the presence of low phosphate. Biophysical Journal 80(1 Part 2): 274a-275a

Cook, E.B.; Stahl, J.L.; Graziano, F.M.; Barney, N.P. 2003: Tnf receptor type i expression on human conjunctival epithelial cells correlation with icam 1 expression. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S271

Milkowski, D.M.; Weiss, R.A. 1999: Tnp 470. Teicher, B A Cancer Drug Discovery and Development Series, 3; Antiangiogenic agents in cancer therapy 385-398

Béjà, O. 2004: To BAC or not to BAC: marine ecogenomics. Current Opinion in Biotechnology 15(3): 187-190

Sharp, J.A.; Waltham, M.; Williams, E.D.; Fisher, L.W.; Thompson, E.W. 2002: To BSP or not to BSP The role of BSP in human breast cancer progression and metastasis. Proceedings of the American Association for Cancer Research 43: 1045

Hohnadel, D.C.; Gruttadauria, M.; Murray, K.; Levin, M.; D'souza, J. 2003: To CO2 or not to CO2, that is the question. Clinical Chemistry 49(S6): A90

Yewdell, J. 2002: To DRiP or not to DRiP: generating peptide ligands for MHC class i molecules from biosynthesized proteins. Molecular Immunology 39(3-4): 139-146

Flock, D.; Siegmann, O. 2004: To Frau Prof Dr Rose-Mariel Wegner on her 80th birthday. Archiv fuer Gefluegelkunde 68(3): 97

Ward, M.D. 2002: To ISO or not to ISO APHIS and NSHS and their decision not to require ISO certification of accredited labs. Phytopathology 92(6 Suppl): S111

Duffard, R. 2000: To a better understanding of the neurodevelopmental effects of phenoxy alkanoic compounds. Biocell 24(Suppl): 25

Chen, C.H.; Li, H.S.; Lin, M.D.; Lin, G. 2001: To a human bodily fluid collection device and method of collecting and absorbing the same. Official Gazette of the United States Patent and Trademark Office Patents 1243(2)

Korotkov, S.M.; Nesterov, V.P.; Schaefer, S. 2002: To a problem of diazoxide effects on isolated rat heart mitochondria. Doklady Akademii Nauk 387(1): 116-120

Piruzyan, L.A.; Piruzyan, A.L. 2004: To a question on an opportunity of use of the physical factors in preventive maintenance and treatment of a number of pathologies. Doklady Akademii Nauk 394(5): 703-706

Piruzyan, L.A.; Malenkov, A.G.; Radkevich, L.A. 2004: To a question on starting mechanisms apoptosis and proliferation hepatocytes at a partial portal ischemia of different duration at rats. Doklady Akademii Nauk 395(2): 261-265

Devereaux, P.J.; Anderson, D.R.; Cox, J.L.; Putnam, W.; Flowerdew, G.J.; Brownell, B.F.; Nagpal, S.; Gardner, M.J. 2000: To anticoagulate or not in atrial fibrillation. Canadian Journal of Cardiology 16(Suppl F): 149F-150F

Graham, S.P. 2001: To anticoagulate or not to anticoagulate patients with cardiomyopathy. Cardiology Clinics 19(4): 605-615

Rizvi, S.A.; Robertson, S.; Krupp, L.B.; Coyle, P.K. 2000: To assess the benefits of brief bed rest on postdural puncture headache. Neurology 54(7 Supp 3): A423

Ahmad, I.; Owens, D.; Ahmed, W.; Khan, H.; Walker, M.; Anderson, G. 1999: To assess the effectiveness of health education in modification of risk behaviour in chronic hepatitis C virus infection acquired by intravenous drug abuse. Gastroenterology 116(4 Part 2): A44

Weaver, C.F.; Rodriguez Kabana, R.; Robertson, D.G. 2002: To assess the long-term effects of selected cropping sequences to control Meloidogyne incognita and increase the yield of cotton. Nematology 4(2): 310

Ellies, P.; Dighiero, P.; Legeais, J.M.; D'hermies, F.; Pouliquen, Y.; Renard, G. 1999: To assess the optimal treatment of corneal dystrophies assay of keratoepithelin mutations are indispensable. IOVS Investigative Ophthalmology and Visual Science 40(4): S332

Galindo, C.; Soler, A.; Sanchez Amat, M.; Valero, A.; Benitez, M.; Fuentes, L.; Dalfo, A.; Vila, M.A.; Aragones, R.; Rebagliato, O. 2004: To be non-dipper A higher cardiovascular risk?. American Journal of Hypertension 17(5

Esbensen, Bente Appel 1999: To be on a side track a qualitative study of BMT patients with focus on the transition from long time hospitalisation and physical isolation to being back home again. European Journal of Cancer 35(Suppl 4): S16

Mitwalli, A.H.; Al Wakeel, J.; Aisha, H.A.; Tarif, N.; Memon, N.; Sulaimani, F. 2000: To be or not to be Isolation of HCV patients in a hemodialysis unit?. Nephrology Dialysis Transplantation 15(9): A212

Caceres, C.E.; Tessier, A.J. 2003: To be or not to be Life history tradeoffs in Daphnia pulicaria. Ecology (Washington D C) 84(5): 1189-1198

Di Santo, J.P.; Radtke, F.; Rodewald, H.R. 2000: To be or not to be a pro-T?. Current Opinion in Immunology 12(2): 159-165

Fiering, S.; Whitelaw, E.; Martin, D.I. 2000: To be or not to be active: the stochastic nature of enhancer action. Bioessays: News and Reviews in Molecular Cellular and Developmental Biology 22(4): 381-387

Webster, J.M.; Walsh, K. 2001: To be or not to be, a symbiont. Phytopathology 91(6 Suppl): S145

Gobetz, K.E. 2004: To bleed or not to bleed Functional significance of nasal foramina in head-lift diggers. Journal of Morphology 260(3): 294

Vitzthum, V.J.; Spielogel, H. 2003: To breed or not to breed Flexible responsiveness of the human female reproductive system to environmental signals. American Journal of Physical Anthropology Suppl (36): 217

Dobson, K.; Lumsden, L.; Nelson, J. 2001: To catch a bat with a harp trap. Bat Research News 42(2): 53

Cannon, C.P. 2002: To cath or not to cath? That used to be the question. American Heart Journal 143(3): 377-380

Mcvoy, J.; Fladby, C.; Jacobitz, K.; Seifert, S.A. 2002: To chart or not to chart What is the answer?. Journal of Toxicology. Clinical Toxicology 40(5): 665

Birth, M.; Strik, M.; Markert, U.; Wohlschlaeger, C.; Bruch, H.P. 2000: To clip or to suture? Prospective-randomised comparison of different biliary reconstruction techniques for orthotopic liver transplantation. Langenbeck's Archives of Surgery 385(8): 545

Fiddler, M.B.; Bayrak-Toydemir, P.; Pergament, E. 2002: To clone or not to clone: who will answer the question?. Differentiation; Research in Biological Diversity 69(4-5): 182-183

Wilmut, I. 2002: To clone or not to clone?. Reproduction Abstract Series (Cambridge) (28): 3

Longobucco, D.; Bernstein, B.; Rossi, D. 2000: To co-bed or not to co-bed? A comparative study of co-bedded versus individually bedded multiple birth infants in the NICU. Pediatric Research 47(4 Part 2): 413A

Stewart, C.C.; Stewart, S.J. 2002: To compensate or not to compensate, improving data quality. Cytometry Suppl (11): 129

Chaufan, C. 2000: To comply or not to comply In search of the real question. Clinical Diabetes 18(1): 46-47

Langat,D.; Cheboiwo,J. 2010: To conserve or not to conserve a case study of forest valuation in Kenya. Journal of Tropical Forest Science 22(1): 5-12

Liaw, Y.n Fan; Chien, Rong Nan; Yeh, Chau Ting; Tsai, Sun Lung; Chu, Chia Ming 2002: To continue or not continue lamivudine therapy after emergence of YMDD mutations. Gastroenterology 122(4 Suppl 1): A 628

Shah, J.M.P. 2003: To correlate risk factors like Atherogenic index in plasma , TG/HDL Ratio, Obesity in Type 2 diabetes mellitus with IHD in India. Diabetologia 46(Suppl 2): A 365

Abati, A. 1999: To count or not to count? a review of the issue of adequacy in breast FNA. Diagnostic Cytopathology 21(2): 142-147

Smith, K.A. 2001: To cure chronic HIV infection, a new therapeutic strategy is needed. Current Opinion in Immunology 13(5): 617-624

Kozarek, R.A. 2002: To cut is divine, to poke is sublime. American Journal of Gastroenterology 97(7): 1586-1587

Malumbres, M.; Barbacid, M. 2001: To cycle or not to cycle A critical decision in cancer. Nature Reviews Cancer 1(3): 222-231

Melamed, E. 2000: To delay or not to delay the start of levodopa therapy. European Journal of Neurology 7(Suppl 3): 4

Bates, V.; Kamran, S.; Empy, H. 1999: To describe the use of telemedicine in acute stroke treatment. Neurology 52(6 Suppl 2): A363

Finney, L.; Solomonidis, S.E. 2000: To determine hyperelastic soft tissue constants for a Finite Element model of an amputees residual limb. Archives of Physiology and Biochemistry 108(1-2): 184

Hendricks, D.E.Jr; Meyers, E.A.; Rhea, J.E.; Vo, K.D.; I'anson, H. 1999: To determine the effect of neurotoxic lesion of the arcuate nucleus on reproductive function in the growth-restricted female rat with delayed puberty. Biology of Reproduction 60(Suppl 1): 252-253

Liou, A.K.F.; Clark, R.S.; Henshall, D.C.; Yin, X-Ming.; Chen, J. 2003: To die or not to die for neurons in ischemia, traumatic brain injury and epilepsy: a review on the stress-activated signaling pathways and apoptotic pathways. Progress in Neurobiology 69(2): 103-142

Lynch, J.P.; Silberg, D.G. 2002: To differentiate or proliferate? the interaction between PI3K/PTEN and Cdx2. Gastroenterology 123(4): 1395-1397

Snow, C.; Riley, J. 2004: To digitize, or not to digitize, is not the question The question is when to digitize. Cytometry 59A(1): 99

Andres, R.; Muller, D.C.; Sorkin, J.D. 2000: To discontinue glucose tolerance or not? Quantification of misdiagnoses from a comprehensive literature review. Diabetes Research and Clinical Practice 50(Suppl 1): S34-S35

Blom, A.W.; Lankaster, B.; Bowker, K.E.; Bannis, G.C. 2001: To disinfect or not to disinfect the foot in total joint arthroplasty of the lower limb. Journal of Hospital Infection 49(4): 304-305

Spalding, H.L. 2001: To dive or not to dive SCUBA versus ROV sampling of macroalgae at 30m depth. Journal of Phycology 37(3 Suppl): 45

Mcevoy, P.M.; Stritzke, W.G.K.; Lang, A.R.; French, D.; Christensen, R. 2001: To drink and not to drink? That is the question Development of a neuromotivational model of craving for alcohol. Alcoholism Clinical and Experimental Research 25(5 Suppl A): 41A

Bissonnette, M.; Wall, A.M.; Wekerle, C.; Mckee, S.A.; Hinson, R.E. 1999: To drink or not to drink? A comparison of alcohol outcome expectancies and coping styles among drinking and abstaining undergraduates. Alcoholism Clinical and Experimental Research 23(5 Suppl): 33A

Flores, H.E. 2000: To dye for Antimicrobial pigments and proteins from underground plant organs. Plant Biology (Rockville) : 9

Einstein, G. 1999: To each her own: sexual dimorphisms in Alzheimer's disease. Neurobiology of Aging 20(4): 439-440

Sobel, N.; Sullivan, E.V.; Gabrieli, J.D.E. 1999: To each nostril the world smells differently Evidence for chromatographic odorant-separation in the human. Society for Neuroscience Abstracts 25(1-2): 1051

Korner, J.; Leibel, R.L. 2003: To eat or not to eat - how the gut talks to the brain. New England Journal of Medicine 349(10): 926-928

Wu, S.H.; Milligan, C.L. 2003: To eat or not to eat The effect of food on metabolic recovery from a bout of exhaustive exercise in adult and juvenile rainbow trout white muscle. SICB Annual Meeting and Exhibition Final Program and Abstracts : 348

Blechert, J.; Feige, B.; Hajcak, G.; Tuschen-Caffier, B. 2010: To eat or not to eat? Availability of food modulates the electrocortical response to food pictures in restrained eaters. Appetite 54(2): 262-268

Nair, P.A.; Feng, Y.; Bell, A.F.; Tonge, P. 2002: To elucidate the mechanism of chromophore formation in red fluorescent protein for discosoma species. Abstracts of Papers American Chemical Society 224(1-2): BIOL 179

Hassold, T.; Hunt, P. 2001: To err is human The genesis of human aneuploidy. Nature Reviews Genetics 2(4): 280-291

D'souza, R.A.B.; Shah, J.M. 2003: To establish correlation between GFR from s creatinine to microalbumin/u creatinine ratio in type 2 DM patients in India. Diabetes and Metabolism 29(Hors serie 2): 4S299-4S300

Grothe, A. 2002: To establish social and educational groups for men with recently discovered prostate cancer Project period 1998 - 2000. International Journal of Cancer Suppl (13): 369

Gauhar, A.; Sheikh, A.L.; Sarwari, A.R. 2000: To evaluate the impact of usage guidelines on meropenem utilization and resistance patterns in a teaching hospital. Pharmacotherapy 20(10): 1247

Saakov, V.S.; Shiryaev, A.V. 2000: To evolution of hypothesis on location of damage influences of environmental factors in green leaf The after-effect of gamma-irradiation on energetic of chloroplasts. Doklady Akademii Nauk 371(2): 280-285

Vissenberg, K.; Verbelen, J.P.; Miller, J.G.; Fry, S.C. 2000: To expand or not to expand, is XET the only answer?. Plant Physiology and Biochemistry (Paris) 38(Suppl): s13

Yeung, K.-S.; Yamanaka, G.A. 2004: To exploit the exploitation of actin by HIV?. Drug Discovery Today 9(1): 2-4

Gruebler, M.; Naef Daenzer, B. 2003: To feed or not to feed? A trade-off in the post-fledging parental care in the double-brooded barn swallow. Vogelwarte 42(1-2): 103-104

Wang, W.; Li, L.-S.; Helms, G.; Zhou, H.-H.; Li, A.D.Q. 2003: To fold or to assemble?. Journal of the American Chemical Society 125(5): 1120-1121